KR20080113624A - Yeast expressing cyclodextrin glucanotransferase and method for using the same - Google Patents
Yeast expressing cyclodextrin glucanotransferase and method for using the same Download PDFInfo
- Publication number
- KR20080113624A KR20080113624A KR1020070062353A KR20070062353A KR20080113624A KR 20080113624 A KR20080113624 A KR 20080113624A KR 1020070062353 A KR1020070062353 A KR 1020070062353A KR 20070062353 A KR20070062353 A KR 20070062353A KR 20080113624 A KR20080113624 A KR 20080113624A
- Authority
- KR
- South Korea
- Prior art keywords
- yeast
- gly
- asn
- thr
- ala
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 120
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 30
- 229920002472 Starch Polymers 0.000 claims abstract description 62
- 239000008107 starch Substances 0.000 claims abstract description 62
- 235000019698 starch Nutrition 0.000 claims abstract description 62
- 235000013305 food Nutrition 0.000 claims abstract description 28
- 230000010354 integration Effects 0.000 claims abstract description 17
- 239000013604 expression vector Substances 0.000 claims abstract description 14
- 210000005253 yeast cell Anatomy 0.000 claims abstract description 10
- 210000004027 cell Anatomy 0.000 claims abstract description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 114
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 239000002157 polynucleotide Substances 0.000 claims description 12
- 102000040430 polynucleotide Human genes 0.000 claims description 12
- 108091033319 polynucleotide Proteins 0.000 claims description 12
- 241000235070 Saccharomyces Species 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 229960000723 ampicillin Drugs 0.000 claims description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 5
- 229930193140 Neomycin Natural products 0.000 claims description 3
- 229960004927 neomycin Drugs 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 230000009261 transgenic effect Effects 0.000 claims description 2
- 230000032683 aging Effects 0.000 abstract description 42
- 239000000463 material Substances 0.000 abstract description 2
- 230000000452 restraining effect Effects 0.000 abstract 1
- 235000008429 bread Nutrition 0.000 description 37
- 239000013598 vector Substances 0.000 description 36
- 102000004190 Enzymes Human genes 0.000 description 18
- 108090000790 Enzymes Proteins 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 16
- 108091008146 restriction endonucleases Proteins 0.000 description 13
- 229920000858 Cyclodextrin Polymers 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 11
- 235000013312 flour Nutrition 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 241000282326 Felis catus Species 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 210000000349 chromosome Anatomy 0.000 description 8
- 239000003292 glue Substances 0.000 description 8
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical group OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 7
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 description 6
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 230000008719 thickening Effects 0.000 description 6
- 108010061238 threonyl-glycine Proteins 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KLALXKYLOMZDQT-ZLUOBGJFSA-N Ala-Ser-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KLALXKYLOMZDQT-ZLUOBGJFSA-N 0.000 description 4
- ZZXMOQIUIJJOKZ-ZLUOBGJFSA-N Asn-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O ZZXMOQIUIJJOKZ-ZLUOBGJFSA-N 0.000 description 4
- QOCFFCUFZGDHTP-NUMRIWBASA-N Asp-Thr-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QOCFFCUFZGDHTP-NUMRIWBASA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 4
- XMPXVJIDADUOQB-RCOVLWMOSA-N Gly-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)CNC(=O)C[NH3+] XMPXVJIDADUOQB-RCOVLWMOSA-N 0.000 description 4
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 4
- IAOZOFPONWDXNT-IXOXFDKPSA-N Phe-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IAOZOFPONWDXNT-IXOXFDKPSA-N 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 108010047857 aspartylglycine Proteins 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 4
- 108010089804 glycyl-threonine Proteins 0.000 description 4
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108010051242 phenylalanylserine Proteins 0.000 description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 101150094690 GAL1 gene Proteins 0.000 description 3
- 102100028501 Galanin peptides Human genes 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 101100121078 Homo sapiens GAL gene Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- -1 polyethylene stearate Polymers 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- SBGXWWCLHIOABR-UHFFFAOYSA-N Ala Ala Gly Ala Chemical compound CC(N)C(=O)NC(C)C(=O)NCC(=O)NC(C)C(O)=O SBGXWWCLHIOABR-UHFFFAOYSA-N 0.000 description 2
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 2
- PXKLCFFSVLKOJM-ACZMJKKPSA-N Ala-Asn-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PXKLCFFSVLKOJM-ACZMJKKPSA-N 0.000 description 2
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 2
- JDIQCVUDDFENPU-ZKWXMUAHSA-N Ala-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CNC=N1 JDIQCVUDDFENPU-ZKWXMUAHSA-N 0.000 description 2
- IFKQPMZRDQZSHI-GHCJXIJMSA-N Ala-Ile-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O IFKQPMZRDQZSHI-GHCJXIJMSA-N 0.000 description 2
- CHFFHQUVXHEGBY-GARJFASQSA-N Ala-Lys-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N CHFFHQUVXHEGBY-GARJFASQSA-N 0.000 description 2
- XSTZMVAYYCJTNR-DCAQKATOSA-N Ala-Met-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XSTZMVAYYCJTNR-DCAQKATOSA-N 0.000 description 2
- CYBJZLQSUJEMAS-LFSVMHDDSA-N Ala-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)N)O CYBJZLQSUJEMAS-LFSVMHDDSA-N 0.000 description 2
- FQNILRVJOJBFFC-FXQIFTODSA-N Ala-Pro-Asp Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N FQNILRVJOJBFFC-FXQIFTODSA-N 0.000 description 2
- DYXOFPBJBAHWFY-JBDRJPRFSA-N Ala-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N DYXOFPBJBAHWFY-JBDRJPRFSA-N 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 2
- DPNHSNLIULPOBH-GUBZILKMSA-N Arg-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N DPNHSNLIULPOBH-GUBZILKMSA-N 0.000 description 2
- TTXYKSADPSNOIF-IHRRRGAJSA-N Arg-Asp-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O TTXYKSADPSNOIF-IHRRRGAJSA-N 0.000 description 2
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 2
- CLICCYPMVFGUOF-IHRRRGAJSA-N Arg-Lys-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O CLICCYPMVFGUOF-IHRRRGAJSA-N 0.000 description 2
- XUGATJVGQUGQKY-ULQDDVLXSA-N Arg-Lys-Phe Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XUGATJVGQUGQKY-ULQDDVLXSA-N 0.000 description 2
- CZUHPNLXLWMYMG-UBHSHLNASA-N Arg-Phe-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 CZUHPNLXLWMYMG-UBHSHLNASA-N 0.000 description 2
- IGFJVXOATGZTHD-UHFFFAOYSA-N Arg-Phe-His Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc2c[nH]cn2)C(=O)O IGFJVXOATGZTHD-UHFFFAOYSA-N 0.000 description 2
- SUMJNGAMIQSNGX-TUAOUCFPSA-N Arg-Val-Pro Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(O)=O SUMJNGAMIQSNGX-TUAOUCFPSA-N 0.000 description 2
- GOVUDFOGXOONFT-VEVYYDQMSA-N Asn-Arg-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GOVUDFOGXOONFT-VEVYYDQMSA-N 0.000 description 2
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 2
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 2
- MSBDSTRUMZFSEU-PEFMBERDSA-N Asn-Glu-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MSBDSTRUMZFSEU-PEFMBERDSA-N 0.000 description 2
- DDPXDCKYWDGZAL-BQBZGAKWSA-N Asn-Gly-Arg Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N DDPXDCKYWDGZAL-BQBZGAKWSA-N 0.000 description 2
- DXVMJJNAOVECBA-WHFBIAKZSA-N Asn-Gly-Asn Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O DXVMJJNAOVECBA-WHFBIAKZSA-N 0.000 description 2
- ACKNRKFVYUVWAC-ZPFDUUQYSA-N Asn-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ACKNRKFVYUVWAC-ZPFDUUQYSA-N 0.000 description 2
- NLRJGXZWTKXRHP-DCAQKATOSA-N Asn-Leu-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NLRJGXZWTKXRHP-DCAQKATOSA-N 0.000 description 2
- JEEFEQCRXKPQHC-KKUMJFAQSA-N Asn-Leu-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JEEFEQCRXKPQHC-KKUMJFAQSA-N 0.000 description 2
- TZFQICWZWFNIKU-KKUMJFAQSA-N Asn-Leu-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 TZFQICWZWFNIKU-KKUMJFAQSA-N 0.000 description 2
- RAUPFUCUDBQYHE-AVGNSLFASA-N Asn-Phe-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RAUPFUCUDBQYHE-AVGNSLFASA-N 0.000 description 2
- IDUUACUJKUXKKD-VEVYYDQMSA-N Asn-Pro-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O IDUUACUJKUXKKD-VEVYYDQMSA-N 0.000 description 2
- WUQXMTITJLFXAU-JIOCBJNQSA-N Asn-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N)O WUQXMTITJLFXAU-JIOCBJNQSA-N 0.000 description 2
- ZAESWDKAMDVHLL-RCOVLWMOSA-N Asn-Val-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O ZAESWDKAMDVHLL-RCOVLWMOSA-N 0.000 description 2
- KBQOUDLMWYWXNP-YDHLFZDLSA-N Asn-Val-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)N)N KBQOUDLMWYWXNP-YDHLFZDLSA-N 0.000 description 2
- MRQQMVZUHXUPEV-IHRRRGAJSA-N Asp-Arg-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MRQQMVZUHXUPEV-IHRRRGAJSA-N 0.000 description 2
- WKGJGVGTEZGFSW-FXQIFTODSA-N Asp-Asn-Met Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O WKGJGVGTEZGFSW-FXQIFTODSA-N 0.000 description 2
- XACXDSRQIXRMNS-OLHMAJIHSA-N Asp-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)O XACXDSRQIXRMNS-OLHMAJIHSA-N 0.000 description 2
- GBSUGIXJAAKZOW-GMOBBJLQSA-N Asp-Ile-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GBSUGIXJAAKZOW-GMOBBJLQSA-N 0.000 description 2
- GYWQGGUCMDCUJE-DLOVCJGASA-N Asp-Phe-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O GYWQGGUCMDCUJE-DLOVCJGASA-N 0.000 description 2
- LIJXJYGRSRWLCJ-IHRRRGAJSA-N Asp-Phe-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LIJXJYGRSRWLCJ-IHRRRGAJSA-N 0.000 description 2
- FAUPLTGRUBTXNU-FXQIFTODSA-N Asp-Pro-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O FAUPLTGRUBTXNU-FXQIFTODSA-N 0.000 description 2
- UXRVDHVARNBOIO-QSFUFRPTSA-N Asp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)N UXRVDHVARNBOIO-QSFUFRPTSA-N 0.000 description 2
- GIKOVDMXBAFXDF-NHCYSSNCSA-N Asp-Val-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GIKOVDMXBAFXDF-NHCYSSNCSA-N 0.000 description 2
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 2
- PONUFVLSGMQFAI-AVGNSLFASA-N Gln-Asn-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PONUFVLSGMQFAI-AVGNSLFASA-N 0.000 description 2
- JKPGHIQCHIIRMS-AVGNSLFASA-N Gln-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N JKPGHIQCHIIRMS-AVGNSLFASA-N 0.000 description 2
- BLOXULLYFRGYKZ-GUBZILKMSA-N Gln-Glu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BLOXULLYFRGYKZ-GUBZILKMSA-N 0.000 description 2
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 2
- JXFLPKSDLDEOQK-JHEQGTHGSA-N Gln-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O JXFLPKSDLDEOQK-JHEQGTHGSA-N 0.000 description 2
- LTUVYLVIZHJCOQ-KKUMJFAQSA-N Glu-Arg-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LTUVYLVIZHJCOQ-KKUMJFAQSA-N 0.000 description 2
- AFODTOLGSZQDSL-PEFMBERDSA-N Glu-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N AFODTOLGSZQDSL-PEFMBERDSA-N 0.000 description 2
- OXEMJGCAJFFREE-FXQIFTODSA-N Glu-Gln-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O OXEMJGCAJFFREE-FXQIFTODSA-N 0.000 description 2
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 2
- JVZLZVJTIXVIHK-SXNHZJKMSA-N Glu-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N JVZLZVJTIXVIHK-SXNHZJKMSA-N 0.000 description 2
- YPHPEHMXOYTEQG-LAEOZQHASA-N Glu-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O YPHPEHMXOYTEQG-LAEOZQHASA-N 0.000 description 2
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 2
- JXYMPBCYRKWJEE-BQBZGAKWSA-N Gly-Arg-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JXYMPBCYRKWJEE-BQBZGAKWSA-N 0.000 description 2
- CIMULJZTTOBOPN-WHFBIAKZSA-N Gly-Asn-Asn Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CIMULJZTTOBOPN-WHFBIAKZSA-N 0.000 description 2
- AIJAPFVDBFYNKN-WHFBIAKZSA-N Gly-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN)C(=O)N AIJAPFVDBFYNKN-WHFBIAKZSA-N 0.000 description 2
- JVWPPCWUDRJGAE-YUMQZZPRSA-N Gly-Asn-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JVWPPCWUDRJGAE-YUMQZZPRSA-N 0.000 description 2
- IWAXHBCACVWNHT-BQBZGAKWSA-N Gly-Asp-Arg Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IWAXHBCACVWNHT-BQBZGAKWSA-N 0.000 description 2
- XEJTYSCIXKYSHR-WDSKDSINSA-N Gly-Asp-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN XEJTYSCIXKYSHR-WDSKDSINSA-N 0.000 description 2
- JPWIMMUNWUKOAD-STQMWFEESA-N Gly-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN JPWIMMUNWUKOAD-STQMWFEESA-N 0.000 description 2
- NPSWCZIRBAYNSB-JHEQGTHGSA-N Gly-Gln-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NPSWCZIRBAYNSB-JHEQGTHGSA-N 0.000 description 2
- SXJHOPPTOJACOA-QXEWZRGKSA-N Gly-Ile-Arg Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SXJHOPPTOJACOA-QXEWZRGKSA-N 0.000 description 2
- XVYKMNXXJXQKME-XEGUGMAKSA-N Gly-Ile-Tyr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XVYKMNXXJXQKME-XEGUGMAKSA-N 0.000 description 2
- HHRODZSXDXMUHS-LURJTMIESA-N Gly-Met-Gly Chemical compound CSCC[C@H](NC(=O)C[NH3+])C(=O)NCC([O-])=O HHRODZSXDXMUHS-LURJTMIESA-N 0.000 description 2
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 2
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 2
- BXDLTKLPPKBVEL-FJXKBIBVSA-N Gly-Thr-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O BXDLTKLPPKBVEL-FJXKBIBVSA-N 0.000 description 2
- PYFHPYDQHCEVIT-KBPBESRZSA-N Gly-Trp-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(O)=O PYFHPYDQHCEVIT-KBPBESRZSA-N 0.000 description 2
- DFHVLUKTTVTCKY-PBCZWWQYSA-N His-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N)O DFHVLUKTTVTCKY-PBCZWWQYSA-N 0.000 description 2
- WCNXUTNLSRWWQN-DCAQKATOSA-N His-Asp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N WCNXUTNLSRWWQN-DCAQKATOSA-N 0.000 description 2
- UWSMZKRTOZEGDD-CUJWVEQBSA-N His-Thr-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O UWSMZKRTOZEGDD-CUJWVEQBSA-N 0.000 description 2
- PZUZIHRPOVVHOT-KBPBESRZSA-N His-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CN=CN1 PZUZIHRPOVVHOT-KBPBESRZSA-N 0.000 description 2
- HERITAGIPLEJMT-GVARAGBVSA-N Ile-Ala-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HERITAGIPLEJMT-GVARAGBVSA-N 0.000 description 2
- HZMLFETXHFHGBB-UGYAYLCHSA-N Ile-Asn-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HZMLFETXHFHGBB-UGYAYLCHSA-N 0.000 description 2
- FJWYJQRCVNGEAQ-ZPFDUUQYSA-N Ile-Asn-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N FJWYJQRCVNGEAQ-ZPFDUUQYSA-N 0.000 description 2
- LEDRIAHEWDJRMF-CFMVVWHZSA-N Ile-Asn-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LEDRIAHEWDJRMF-CFMVVWHZSA-N 0.000 description 2
- NBJAAWYRLGCJOF-UGYAYLCHSA-N Ile-Asp-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N NBJAAWYRLGCJOF-UGYAYLCHSA-N 0.000 description 2
- GYAFMRQGWHXMII-IUKAMOBKSA-N Ile-Asp-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N GYAFMRQGWHXMII-IUKAMOBKSA-N 0.000 description 2
- LKACSKJPTFSBHR-MNXVOIDGSA-N Ile-Gln-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N LKACSKJPTFSBHR-MNXVOIDGSA-N 0.000 description 2
- DVRDRICMWUSCBN-UKJIMTQDSA-N Ile-Gln-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N DVRDRICMWUSCBN-UKJIMTQDSA-N 0.000 description 2
- BEWFWZRGBDVXRP-PEFMBERDSA-N Ile-Glu-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O BEWFWZRGBDVXRP-PEFMBERDSA-N 0.000 description 2
- FUOYNOXRWPJPAN-QEWYBTABSA-N Ile-Glu-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N FUOYNOXRWPJPAN-QEWYBTABSA-N 0.000 description 2
- GQKSJYINYYWPMR-NGZCFLSTSA-N Ile-Gly-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N GQKSJYINYYWPMR-NGZCFLSTSA-N 0.000 description 2
- YNMQUIVKEFRCPH-QSFUFRPTSA-N Ile-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O)N YNMQUIVKEFRCPH-QSFUFRPTSA-N 0.000 description 2
- WVUDHMBJNBWZBU-XUXIUFHCSA-N Ile-Lys-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)O)N WVUDHMBJNBWZBU-XUXIUFHCSA-N 0.000 description 2
- VEPIBPGLTLPBDW-URLPEUOOSA-N Ile-Phe-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N VEPIBPGLTLPBDW-URLPEUOOSA-N 0.000 description 2
- CAHCWMVNBZJVAW-NAKRPEOUSA-N Ile-Pro-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)N CAHCWMVNBZJVAW-NAKRPEOUSA-N 0.000 description 2
- CNMOKANDJMLAIF-CIQUZCHMSA-N Ile-Thr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O CNMOKANDJMLAIF-CIQUZCHMSA-N 0.000 description 2
- XVUAQNRNFMVWBR-BLMTYFJBSA-N Ile-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N XVUAQNRNFMVWBR-BLMTYFJBSA-N 0.000 description 2
- OMDWJWGZGMCQND-CFMVVWHZSA-N Ile-Tyr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OMDWJWGZGMCQND-CFMVVWHZSA-N 0.000 description 2
- GNXGAVNTVNOCLL-SIUGBPQLSA-N Ile-Tyr-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N GNXGAVNTVNOCLL-SIUGBPQLSA-N 0.000 description 2
- RMJWFINHACYKJI-SIUGBPQLSA-N Ile-Tyr-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RMJWFINHACYKJI-SIUGBPQLSA-N 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 2
- ZRLUISBDKUWAIZ-CIUDSAMLSA-N Leu-Ala-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O ZRLUISBDKUWAIZ-CIUDSAMLSA-N 0.000 description 2
- WSGXUIQTEZDVHJ-GARJFASQSA-N Leu-Ala-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O WSGXUIQTEZDVHJ-GARJFASQSA-N 0.000 description 2
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 2
- VIWUBXKCYJGNCL-SRVKXCTJSA-N Leu-Asn-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 VIWUBXKCYJGNCL-SRVKXCTJSA-N 0.000 description 2
- FMEICTQWUKNAGC-YUMQZZPRSA-N Leu-Gly-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O FMEICTQWUKNAGC-YUMQZZPRSA-N 0.000 description 2
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 2
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 2
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 2
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 2
- ISSAURVGLGAPDK-KKUMJFAQSA-N Leu-Tyr-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O ISSAURVGLGAPDK-KKUMJFAQSA-N 0.000 description 2
- FACUGMGEFUEBTI-SRVKXCTJSA-N Lys-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN FACUGMGEFUEBTI-SRVKXCTJSA-N 0.000 description 2
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 2
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 2
- PYFNONMJYNJENN-AVGNSLFASA-N Lys-Lys-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PYFNONMJYNJENN-AVGNSLFASA-N 0.000 description 2
- PLDJDCJLRCYPJB-VOAKCMCISA-N Lys-Lys-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PLDJDCJLRCYPJB-VOAKCMCISA-N 0.000 description 2
- LNMKRJJLEFASGA-BZSNNMDCSA-N Lys-Phe-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O LNMKRJJLEFASGA-BZSNNMDCSA-N 0.000 description 2
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 2
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- 108010066427 N-valyltryptophan Proteins 0.000 description 2
- 108010047562 NGR peptide Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- AJOKKVTWEMXZHC-DRZSPHRISA-N Phe-Ala-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 AJOKKVTWEMXZHC-DRZSPHRISA-N 0.000 description 2
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 2
- CSYVXYQDIVCQNU-QWRGUYRKSA-N Phe-Asp-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O CSYVXYQDIVCQNU-QWRGUYRKSA-N 0.000 description 2
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 2
- YFXXRYFWJFQAFW-JHYOHUSXSA-N Phe-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O YFXXRYFWJFQAFW-JHYOHUSXSA-N 0.000 description 2
- FZHBZMDRDASUHN-NAKRPEOUSA-N Pro-Ala-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(O)=O FZHBZMDRDASUHN-NAKRPEOUSA-N 0.000 description 2
- SBYVDRLQAGENMY-DCAQKATOSA-N Pro-Asn-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O SBYVDRLQAGENMY-DCAQKATOSA-N 0.000 description 2
- CJZTUKSFZUSNCC-FXQIFTODSA-N Pro-Asp-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 CJZTUKSFZUSNCC-FXQIFTODSA-N 0.000 description 2
- ZPPVJIJMIKTERM-YUMQZZPRSA-N Pro-Gln-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]1CCCN1 ZPPVJIJMIKTERM-YUMQZZPRSA-N 0.000 description 2
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 2
- ZZCJYPLMOPTZFC-SRVKXCTJSA-N Pro-Met-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(O)=O ZZCJYPLMOPTZFC-SRVKXCTJSA-N 0.000 description 2
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 2
- VGNYHOBZJKWRGI-CIUDSAMLSA-N Ser-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO VGNYHOBZJKWRGI-CIUDSAMLSA-N 0.000 description 2
- BNFVPSRLHHPQKS-WHFBIAKZSA-N Ser-Asp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O BNFVPSRLHHPQKS-WHFBIAKZSA-N 0.000 description 2
- MPPHJZYXDVDGOF-BWBBJGPYSA-N Ser-Cys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CO MPPHJZYXDVDGOF-BWBBJGPYSA-N 0.000 description 2
- BQWCDDAISCPDQV-XHNCKOQMSA-N Ser-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N)C(=O)O BQWCDDAISCPDQV-XHNCKOQMSA-N 0.000 description 2
- UAJAYRMZGNQILN-BQBZGAKWSA-N Ser-Gly-Met Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UAJAYRMZGNQILN-BQBZGAKWSA-N 0.000 description 2
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 2
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 2
- TVPQRPNBYCRRLL-IHRRRGAJSA-N Ser-Phe-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O TVPQRPNBYCRRLL-IHRRRGAJSA-N 0.000 description 2
- BSXKBOUZDAZXHE-CIUDSAMLSA-N Ser-Pro-Glu Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O BSXKBOUZDAZXHE-CIUDSAMLSA-N 0.000 description 2
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 2
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 2
- FLMYSKVSDVHLEW-SVSWQMSJSA-N Ser-Thr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLMYSKVSDVHLEW-SVSWQMSJSA-N 0.000 description 2
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 2
- PQEQXWRVHQAAKS-SRVKXCTJSA-N Ser-Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=C(O)C=C1 PQEQXWRVHQAAKS-SRVKXCTJSA-N 0.000 description 2
- UKKROEYWYIHWBD-ZKWXMUAHSA-N Ser-Val-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UKKROEYWYIHWBD-ZKWXMUAHSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- LVHHEVGYAZGXDE-KDXUFGMBSA-N Thr-Ala-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(=O)O)N)O LVHHEVGYAZGXDE-KDXUFGMBSA-N 0.000 description 2
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 2
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 2
- CRZNCABIJLRFKZ-IUKAMOBKSA-N Thr-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N CRZNCABIJLRFKZ-IUKAMOBKSA-N 0.000 description 2
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 2
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 2
- OLFOOYQTTQSSRK-UNQGMJICSA-N Thr-Pro-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLFOOYQTTQSSRK-UNQGMJICSA-N 0.000 description 2
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 2
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 2
- VUXIQSUQQYNLJP-XAVMHZPKSA-N Thr-Ser-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N)O VUXIQSUQQYNLJP-XAVMHZPKSA-N 0.000 description 2
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 2
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 2
- XGUAUKUYQHBUNY-SWRJLBSHSA-N Thr-Trp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O XGUAUKUYQHBUNY-SWRJLBSHSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- WACMTVIJWRNVSO-CWRNSKLLSA-N Trp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N)C(=O)O WACMTVIJWRNVSO-CWRNSKLLSA-N 0.000 description 2
- ZJKZLNAECPIUTL-JBACZVJFSA-N Trp-Gln-Tyr Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 ZJKZLNAECPIUTL-JBACZVJFSA-N 0.000 description 2
- AZBIIKDSDLVJAK-VHWLVUOQSA-N Trp-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N AZBIIKDSDLVJAK-VHWLVUOQSA-N 0.000 description 2
- OGZRZMJASKKMJZ-XIRDDKMYSA-N Trp-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N OGZRZMJASKKMJZ-XIRDDKMYSA-N 0.000 description 2
- GDPDVIBHJDFRFD-RNXOBYDBSA-N Trp-Tyr-Tyr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GDPDVIBHJDFRFD-RNXOBYDBSA-N 0.000 description 2
- XLMDWQNAOKLKCP-XDTLVQLUSA-N Tyr-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N XLMDWQNAOKLKCP-XDTLVQLUSA-N 0.000 description 2
- MBFJIHUHHCJBSN-AVGNSLFASA-N Tyr-Asn-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MBFJIHUHHCJBSN-AVGNSLFASA-N 0.000 description 2
- FQNUWOHNGJWNLM-QWRGUYRKSA-N Tyr-Cys-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)NCC(O)=O FQNUWOHNGJWNLM-QWRGUYRKSA-N 0.000 description 2
- KEHKBBUYZWAMHL-DZKIICNBSA-N Tyr-Gln-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O KEHKBBUYZWAMHL-DZKIICNBSA-N 0.000 description 2
- KCPFDGNYAMKZQP-KBPBESRZSA-N Tyr-Gly-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O KCPFDGNYAMKZQP-KBPBESRZSA-N 0.000 description 2
- YYZPVPJCOGGQPC-JYJNAYRXSA-N Tyr-His-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYZPVPJCOGGQPC-JYJNAYRXSA-N 0.000 description 2
- MVYRJYISVJWKSX-KBPBESRZSA-N Tyr-His-Gly Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)NCC(=O)O)N)O MVYRJYISVJWKSX-KBPBESRZSA-N 0.000 description 2
- DMWNPLOERDAHSY-MEYUZBJRSA-N Tyr-Leu-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DMWNPLOERDAHSY-MEYUZBJRSA-N 0.000 description 2
- OKDNSNWJEXAMSU-IRXDYDNUSA-N Tyr-Phe-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 OKDNSNWJEXAMSU-IRXDYDNUSA-N 0.000 description 2
- XGZBEGGGAUQBMB-KJEVXHAQSA-N Tyr-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=C(C=C2)O)N)O XGZBEGGGAUQBMB-KJEVXHAQSA-N 0.000 description 2
- TYFLVOUZHQUBGM-IHRRRGAJSA-N Tyr-Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TYFLVOUZHQUBGM-IHRRRGAJSA-N 0.000 description 2
- BIVIUZRBCAUNPW-JRQIVUDYSA-N Tyr-Thr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O BIVIUZRBCAUNPW-JRQIVUDYSA-N 0.000 description 2
- ZYVAAYAOTVJBSS-GMVOTWDCSA-N Tyr-Trp-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O ZYVAAYAOTVJBSS-GMVOTWDCSA-N 0.000 description 2
- WYOBRXPIZVKNMF-IRXDYDNUSA-N Tyr-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 WYOBRXPIZVKNMF-IRXDYDNUSA-N 0.000 description 2
- UEOOXDLMQZBPFR-ZKWXMUAHSA-N Val-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N UEOOXDLMQZBPFR-ZKWXMUAHSA-N 0.000 description 2
- VJOWWOGRNXRQMF-UVBJJODRSA-N Val-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 VJOWWOGRNXRQMF-UVBJJODRSA-N 0.000 description 2
- AUMNPAUHKUNHHN-BYULHYEWSA-N Val-Asn-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N AUMNPAUHKUNHHN-BYULHYEWSA-N 0.000 description 2
- ISERLACIZUGCDX-ZKWXMUAHSA-N Val-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N ISERLACIZUGCDX-ZKWXMUAHSA-N 0.000 description 2
- CELJCNRXKZPTCX-XPUUQOCRSA-N Val-Gly-Ala Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O CELJCNRXKZPTCX-XPUUQOCRSA-N 0.000 description 2
- VHRLUTIMTDOVCG-PEDHHIEDSA-N Val-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](C(C)C)N VHRLUTIMTDOVCG-PEDHHIEDSA-N 0.000 description 2
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 2
- MLADEWAIYAPAAU-IHRRRGAJSA-N Val-Lys-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MLADEWAIYAPAAU-IHRRRGAJSA-N 0.000 description 2
- VNGKMNPAENRGDC-JYJNAYRXSA-N Val-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=CC=C1 VNGKMNPAENRGDC-JYJNAYRXSA-N 0.000 description 2
- XBJKAZATRJBDCU-GUBZILKMSA-N Val-Pro-Ala Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O XBJKAZATRJBDCU-GUBZILKMSA-N 0.000 description 2
- VIKZGAUAKQZDOF-NRPADANISA-N Val-Ser-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O VIKZGAUAKQZDOF-NRPADANISA-N 0.000 description 2
- YQYFYUSYEDNLSD-YEPSODPASA-N Val-Thr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O YQYFYUSYEDNLSD-YEPSODPASA-N 0.000 description 2
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 2
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 2
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 2
- DOBHJKVVACOQTN-DZKIICNBSA-N Val-Tyr-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 DOBHJKVVACOQTN-DZKIICNBSA-N 0.000 description 2
- JXWGBRRVTRAZQA-ULQDDVLXSA-N Val-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N JXWGBRRVTRAZQA-ULQDDVLXSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 108010011559 alanylphenylalanine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 108010059459 arginyl-threonyl-phenylalanine Proteins 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 108010092114 histidylphenylalanine Proteins 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 108010078274 isoleucylvaline Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 239000012913 medium supplement Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 108010056582 methionylglutamic acid Proteins 0.000 description 2
- 108010034507 methionyltryptophan Proteins 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 108010003885 valyl-prolyl-glycyl-glycine Proteins 0.000 description 2
- 108010073969 valyllysine Proteins 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical compound CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 description 1
- KUNFMZSTKSLIEY-GRHHLOCNSA-N (2s)-2-azanyl-3-phenyl-propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=CC=C1 KUNFMZSTKSLIEY-GRHHLOCNSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- UGEZSPWLJABDAR-KKUMJFAQSA-N Gln-Tyr-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)N)N UGEZSPWLJABDAR-KKUMJFAQSA-N 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 241000481961 Lachancea thermotolerans Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000877399 Saccharomyces chevalieri Species 0.000 description 1
- 235000018370 Saccharomyces delbrueckii Nutrition 0.000 description 1
- 241000582914 Saccharomyces uvarum Species 0.000 description 1
- YQQKYAZABFEYAF-FXQIFTODSA-N Ser-Glu-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQQKYAZABFEYAF-FXQIFTODSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- 244000288561 Torulaspora delbrueckii Species 0.000 description 1
- 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- OGPKMBOPMDTEDM-IHRRRGAJSA-N Tyr-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N OGPKMBOPMDTEDM-IHRRRGAJSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003916 calcium stearoyl-2-lactylate Substances 0.000 description 1
- OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 description 1
- 235000010957 calcium stearoyl-2-lactylate Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000012470 frozen dough Nutrition 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000012471 refrigerated dough Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 239000003724 sodium stearoyl-2-lactylate Substances 0.000 description 1
- 235000010956 sodium stearoyl-2-lactylate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000007221 ypg medium Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/18—Carbohydrates
- A21D2/186—Starches; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/1074—Cyclomaltodextrin glucanotransferase (2.4.1.19)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/5118—Starch
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01019—Cyclomaltodextrin glucanotransferase (2.4.1.19)
Abstract
Description
도 1은 본원 발명의 일 실시예에 따른 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자를 효모에 형질전환시키기 위한 재조합 플라스미드 pδCGT[3-18]를 제조하는 과정을 나타낸 그림이다.1 is a diagram illustrating a process for preparing a recombinant plasmid pδCGT [3-18] for transforming a cyclodextrin glucanotransferase gene into yeast according to an embodiment of the present invention.
도 2는 본원 발명의 일 실시예에 따른 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자를 효모에 형질전환시키기 위해 제조된 재조합 플라스미드 pδCGT[3-18]-2를 나타낸 그림이다.2 is a diagram showing a recombinant plasmid pδCGT [3-18] -2 prepared for transforming a cyclodextrin glucanotransferase gene into yeast according to an embodiment of the present invention.
도 3는 본 발명의 일 실시예에 따른 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자를 형질전환시킨 효모와 야생형의 대조군 효모의 냉해동 안정성을 나타낸 그림이다.Figure 3 is a diagram showing the freeze stability of the yeast and wild-type control yeast transformed cyclodextrin glucanotransferase gene according to an embodiment of the present invention.
도 4은 본 발명의 일 실시예에 따른 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 재조합 효모인 S. cerevisiae/pδCGT와 싸이클로덱스트린 글루카노트랜스퍼레이즈가 포함되지 아니한 재조합 벡터인 pδYD1을 형질전환시킨 재조합 효모인 S. cerevisiae/pδYD1를 이용하여 제조한 빵의 상대적 부피를 측정한 그림이다.4 is a recombinant recombinant S. cerevisiae / pδCGT and a recombinant vector pδYD1 which does not contain cyclodextrin glucanotransferase expressed on the surface of the cyclodextrin glucanotransferase according to an embodiment of the present invention This figure shows the relative volume of bread prepared using yeast S. cerevisiae / pδYD1.
도 5는 본 발명의 일 실시예에 따른 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 재조합 효모인 S. cerevisiae/pδCGT와 싸이클로덱스트린 글루카노트랜스퍼레이즈가 포함되지 아니한 재조합 벡터 pδYD1을 형질전환시킨 재조합 효모인 S. cerevisiae/pδYD1를 이용하여 제조한 증편의 상대적 부피를 측정한 그림이다.5 is a recombinant yeast transformed with a recombinant vector pδYD1 that does not contain S. cerevisiae / pδCGT, which is a recombinant yeast expressed on the surface of a cyclodextrin glucanotransferase, and a cyclodextrin glucanotransferase according to an embodiment of the present invention. The relative volume of Jeungpyun prepared using S. cerevisiae / pδYD1 was measured.
도 6는 본 발명의 일 실시예에 따른 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 재조합 효모인 S. cerevisiae/pδCGT와 싸이클로덱스트린 글루카노트랜스퍼레이즈가 포함되지 아니한 재조합 벡터를 형질전환시킨 재조합 효모인 S. cerevisiae/pδYD1를 이용하여 제조한 빵의 노화도를 시차주사열량계를 이용하여 측정한 그림이다.6 is a recombinant yeast transformed from a recombinant vector containing S. cerevisiae / pδCGT, which is a recombinant yeast expressed on the surface of the cyclodextrin glucanotransferase according to one embodiment of the present invention, and which does not include the cyclodextrin glucanotransferase The aging degree of bread prepared using S. cerevisiae / pδYD1 was measured using a differential scanning calorimeter.
도 7은 본 발명의 일 실시예에 따른 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 재조합 효모인 S. cerevisiae/pδCGT와 싸이클로덱스트린 글루카노트랜스퍼레이즈가 포함되지 아니한 재조합 벡터를 형질전환시킨 재조합 효모인 S. cerevisiae/pδYD1를 이용하여 제조한 증편의 노화도를 시차주사열량계를 이용하여 측정한 그림이다.7 is a recombinant yeast transformed with a recombinant vector containing S. cerevisiae / pδCGT, which is a recombinant yeast expressed on the surface of a cyclodextrin glucanotransferase, and a cyclodextrin glucanotransferase according to an embodiment of the present invention. The aging degree of Jeungpyun prepared using S. cerevisiae / pδYD1 was measured by differential scanning calorimetry.
도 8은 본 발명의 일 실시예에 따른 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 재조합 효모인 S. cerevisiae/pδCGT를 이용하여 제조한 빵에 존재하는 소당류들을 고속 액상크로마토그래피(HPLC)를 이용하여 분석한 그림이다. 8 is a high-performance liquid chromatography (HPLC) of small sugars present in bread prepared using S. cerevisiae / pδCGT, which is a recombinant yeast expressed on a surface of cyclodextrin glucanotransferase according to an embodiment of the present invention. It is a picture analyzed using.
도 9는 본 발명의 일 실시예에 따른 pR2CGT [3-18](Protein Eng . Des . Sel ., 17, pp205-211(2004))로부터 수득한 싸이클로덱스트린 글루카노트랜스퍼레이즈를 코딩하는 폴리뉴클레오타이드 서열을 나타낸 그림이다. 9 is pR 2 CGT [3-18] ( Protein according to an embodiment of the present invention) Eng . Des . Sel . , 17, pp205-211 (2004)) is a figure showing the polynucleotide sequence encoding the cyclodextrin glucanotransferase.
도 10는 본 발명의 일 실시예에 따른 인테그레이션 부위인 δ시퀀스(δsequence)의 서열을 나타낸 그림이다.10 is a diagram showing the sequence of the δ sequence (δ sequence) which is an integration site according to an embodiment of the present invention.
[발명이 속하는 기술분야][TECHNICAL FIELD OF THE INVENTION]
본 발명은 전분의 노화억제 효과가 있는 싸이클로덱스트린 글루카노트랜스퍼레이즈를 발현하는 효모 및 상기 효모를 이용하여 빵 또는 증편을 제조하는 방법에 관한 것으로, 상기 효모를 이용하는 경우 별도의 효소 처리 없이 제품의 노화를 지연시킬 수 있으므로 식품 산업에 매우 유용하게 사용될 수 있다. The present invention relates to a yeast expressing cyclodextrin glucanotransferase having an anti-aging effect of starch and a method for preparing bread or enlargement using the yeast, and aging of a product without additional enzyme treatment when using the yeast. This can be very useful for the food industry.
[종래기술][Private Technology]
식품분야에서 널리 사용되고 있는 전분은 아밀로오스(amylase)와 아밀로펙틴(amylopectin)으로 구성되어 있으며 수용액 중에서 어느 일정한 온도 이상으로 가열되면 전분입자가 팽윤되면서 입자가 무질서한 상태로 되어 결정성이 소실된 호화상태로 된다. 통상적으로 전분이 포함된 식품은 수분과 함께 가열하여 소화되기 쉬운 상태로 제조되고 유통되게 된다. 그러나, 전분을 포함한 식품은 저장하는 동안에 상기 호화된 전분이 노화되는 경향이 있다.Starch widely used in the food field is composed of amylase and amylopectin, and when heated above a certain temperature in aqueous solution, the starch particles swell and become disorganized, resulting in a loss of crystallinity. . Typically, food containing starch is prepared and distributed in a digestible state by heating with moisture. However, foods containing starch tend to age the gelatinized starch during storage.
상기 전분의 노화는 식품을 장기간 저장하는 경우, 식품 내 수분이 감소하는 과정에서 아밀로펙틴 크리스탈을 형성하는 현상을 말한다. 보다 상세하게는, 호화전분을 실온에 장시간 방치하는 경우에 전분분자들이 수소결합에 의해 다시 회합(association)되어 즉, 미세한 결정을 형성하는 현상 즉, 알파화된 전분(호화전분)이 베타전분으로 되돌아가는 현상을 의미한다. 전분의 노화에 영향을 주는 인자들은 전분의 종류, 전분의 농도, pH, 수분, 온도, 염과 각종 이온의 존재 등이 영향을 미친다. 예를 들어, 아밀로오스 함량이 높은 전분은 노화가 잘 일어나고, 산성조건이나 60 ℃ 이하에서 노화가 촉진되는 반면, 염과 각종이온이 존재하는 경우에는 노화가 억제된다.The aging of the starch refers to a phenomenon in which amylopectin crystals are formed in a process of decreasing moisture in the food when the food is stored for a long time. More specifically, when gelatinized starch is left at room temperature for a long time, the starch molecules are associated again by hydrogen bonding, that is, a phenomenon in which fine crystals are formed, that is, alpha starch (gelatinized starch) becomes beta starch. It means a return phenomenon. Factors affecting aging of starch are influenced by starch type, starch concentration, pH, moisture, temperature, presence of salts and various ions. For example, starch with high amylose content is aging well, and aging is promoted under acidic conditions or below 60 ° C., whereas aging is suppressed when salts and various ions are present.
전분이 포함된 제품 특히, 식품이 노화되는 경우 여러 가지 문제점이 발생 된다. 예를 들어, 전분을 포함한 식품이 노화되는 경우 맛과 풍미의 열화(Deterioration of taste and flavor), 경도(toughness)의 증가나 보수성(water retention capacity)의 증가 등으로 인한 제품의 품질 저하가 문제된다.Many problems arise when products containing starch, especially food, age. For example, when food containing starch ages, deterioration of product quality due to deterioration of taste and flavor, increase in toughness or increase in water retention capacity is a problem. .
특히, 상기 전분을 포함하는 식품에서 전분의 노화는 품질뿐만 아니라 제품의 유통기한에 큰 영향을 미친다. 특히, 전분의 노화속도는 전통식품인 증편이나 빵 등에서 매우 빨라서, 전분의 노화는 증편이나 빵 등의 대량생산 및 제품화에 큰 어려움이 되고 있다. In particular, aging of starch in the food containing the starch has a great influence on the shelf life of the product as well as quality. In particular, the aging rate of starch is very fast in Jeungpyeon or bread, which is a traditional food, and aging of starch is a great difficulty in mass production and commercialization of Jeungpyeon and bread.
상기와 같은 문제점을 해결하기 위하여, 전분이 포함된 제품에 대해 여러 가지 전분의 노화 억제방법(preventive measures of retorogradation)이 사용되고 있다. 상기 전분의 노화 억제방법으로는 수분함량의 조절, 냉동, 설탕이나 유화제의 첨가 등이 있으며, 최근에는 효소를 사용하는 방법이 널리 사용되고 있다. In order to solve the above problems, a variety of starch measures (preventive measures of retorogradation) has been used for starch-containing products. As a method of inhibiting aging of starch, there are control of water content, freezing, addition of sugar and emulsifier, etc. Recently, a method using an enzyme has been widely used.
상기 효소처리법과 관련하여, 일반적으로 사용되는 전분의 노화억제 효소는 Novamyl과 같이 상용화된 효소로 이들 대부분은 외국의 제조사로부터 수입하여 사용되고 있다. 상기와 같은 노화억제효소로는 다양한 알파아밀레이즈, 싸이클로덱스트린 글루카노트랜스퍼레이즈 등이 연구되고 있다. 그러나 상기와 같은 효소처리법은 제품의 제조시에 효소를 첨가하여야 하기 때문에, 효소구매 및 효소첨가 공정이라는 추가 공정으로 인한 비용 증가 때문에, 그 사용이 일부 제품에 한정되는 문제점이 있다. In relation to the enzyme treatment method, the starch aging inhibitor of commonly used starch is a commercially available enzyme such as Novamyl, most of which are imported from foreign manufacturers. As the anti-aging enzymes as described above, various alpha amylase, cyclodextrin glucanotransferase, and the like have been studied. However, the enzyme treatment method described above has a problem in that its use is limited to some products because of the increased cost due to the additional process such as the enzyme purchase and the enzyme addition process, since the enzyme must be added during the manufacture of the product.
따라서, 상기 효소 처리를 보다 간단한 공정으로 처리할 수 있는 방법에 대한 연구의 필요성이 증가하고 있다.Thus, there is an increasing need for research into a method that can process the enzyme treatment in a simpler process.
본 발명의 목적은 전분의 노화억제에 효과가 있는 싸이클로덱스트린 글루카노트랜스퍼레이즈를 발현하는 형질전환된 효모를 제공하는 것이다.It is an object of the present invention to provide a transformed yeast expressing cyclodextrin glucanotransferase that is effective in inhibiting aging of starch.
본 발명의 또 다른 목적은 상기 형질전환된 효모를 이용하는 방법에 관한 것이다.Another object of the invention relates to a method of using the transformed yeast.
상기와 같은 목적을 달성하기 위하여, 본 발명은 전분의 노화억제에 효과가 있는 싸이클로덱스트린 글루카노트랜스퍼레이즈를 발현하는 형질전환된 효모를 제공한다.In order to achieve the above object, the present invention provides a transformed yeast expressing cyclodextrin glucanotransferase that is effective in inhibiting aging of starch.
또한, 본 발명은 상기와 같은 목적을 달성하기 위하여, 상기 형질전환된 효모를 이용하는 방법, 보다 상세하게는 상기 형질전환된 효모를 이용하여 빵 또는 증편을 제조하는 방법에 관한 것이다.In addition, the present invention relates to a method of using the transformed yeast, and more particularly to a bread or a Jeungpyun using the transformed yeast in order to achieve the above object.
본 발명자들은 상기와 같은 문제점을 극복하기 위하여 지속적으로 연구한 결과, 전분이 포함된 식품의 제조에 효모의 표면에 전분의 노화억제 효소를 발현시킨 효모를 사용함으로써 추가적인 효소의 첨가 공정 없이 제품의 노화를 억제할 수 있다는 것을 발견하여 본 발명을 완성하였다.The present inventors have continuously studied to overcome the above problems, and as a result of using the yeast expressing the starch aging inhibitor enzyme on the surface of the yeast in the production of food containing starch, aging of the product without the addition of additional enzyme The present invention was completed by discovering that it can be suppressed.
이하, 본 발명을 상세하게 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail.
본 발명은 전분의 노화억제에 효과가 있는 싸이클로덱스트린 글루카노트랜스퍼레이즈, 프로모터 및 인테그레이션 부위(integration site)을 포함하는 형질전환 효모 제조용 벡터에 관한 것이다.The present invention relates to a vector for producing a transformed yeast comprising a cyclodextrin glucanotransferase, a promoter and an integration site, which are effective in inhibiting aging of starch.
보다 상세하게는, 전분의 노화억제에 효과가 있는 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자, 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자의 상부에 작동가능하게 연결된 프로모터 및 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자가 효모의 게놈에 병합가능하도록 인테그레이션하는 인테그레이션 부위(integration site) 즉, 인테그레이션 폴리뉴클레오타이드 서열을 포함하며, 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈가 효모의 세포표면에 발현되는 것을 특징으로 하는 효모세포 발현용 벡터 또는 형질전환 효모 제조용 벡터에 관한 것이다.More specifically, the cyclodextrin glucanotransferase gene, the promoter operably linked to the upper part of the cyclodextrin glucanotransferase gene, and the cyclodextrin glucanotransferase gene, which are effective in inhibiting the aging of starch, are genomes of yeast. Yeast cell expression vector or transformed yeast comprising an integration site, i.e., an integration polynucleotide sequence, that is integrated so as to be integrated into the yeast cell, wherein the cyclodextrin glucanotransferase is expressed on the cell surface of the yeast. It relates to a production vector.
상기 효모세포 발현용 벡터는 선택성 표지(selective marker)를 추가로 포함하는 것일 수 있으며, 상기 선택성 표지는 형질전환 여부를 확인할 수 있는 통상의 선택성 표지일 수 있고, 바람직하게는 암피실린 저항성 유전자(Ampicillin resistance gene, Amp(r)) 및/또는 네오마이신 저항성 유전자(Neomycin resistance gene, Neo(r))일 수 있다.The yeast cell expression vector may further include a selective marker, and the selective marker may be a conventional selective marker capable of confirming transformation, and preferably an ampicillin resistance gene (Ampicillin resistance). gene, Amp (r)) and / or Neomycin resistance gene (Neo (r)).
상기 싸이클로덱스트린 글루카노트랜스퍼레이즈는 통상적인 싸이클로덱스트린 글루카노트랜스퍼레이즈일 수 있으며, 바람직하게는 싸이클로덱스트린 글루카노트랜스퍼레이즈(Accesion No. AY478421)일 수 있으며, 더욱 바람직하게는 pR2CGT [3-18](Protein Eng . Des . Sel ., 17, pp 205-211(2004))로부터 수득한 싸이클로덱스트린 글루카노트랜스퍼레이즈일 수 있고, 가장 바람직하게는 서열번호 6의 싸이클로덱스트린 글루카노트랜스퍼레이즈일 수 있다. The cyclodextrin glucanotransferase may be a conventional cyclodextrin glucanotransferase, preferably may be a cyclodextrin glucanotransferase (Accesion No. AY478421), more preferably pR 2 CGT [3-18] ] (Cyclodextrin glucanotransferase obtained from Protein Eng . Des . Sel . , 17, pp 205-211 (2004)), most preferably the cyclodextrin glucanotransase of SEQ ID NO: 6. .
상기 pR2CGT [3-18](Protein Eng . Des . Sel ., 17, pp 205-211(2004))로부터 수득한 싸이클로덱스트린 글루카노트랜스퍼레이즈는 바람직하게는 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈(Accesion No. AY478421)의 234번째 아미노산 서열을 메티오닌(Methionine)에서 트레오닌(Threonine)으로 치환하고, 259번째 아미노산 서열을 페닐알라닌(Phenylalanine)에서 이소류신(Isoleucine)으로 치환하며, 591번째 아미노산 서열을 발린(Methionine)에서 알라닌(Alanine)으로 치환한 싸이클로덱스트린 글루카노트랜스퍼레이즈일 수 있으며, 구체적으로는 서열번호 6의 싸이클로덱스트린 글루카노트랜스퍼레이즈일 수 있고, 바람직하게는 도 9 및 서열번호 5에 기재된 폴리뉴틀레오타이드에 의해 코딩되는 싸이클로덱스트린 글루카노트랜스퍼레이즈일 수 있다. PR 2 CGT [3-18] ( Protein Eng . Des . Sel . , 17, pp 205-211 (2004)), the cyclodextrin glucanotransferase preferably comprises the threonine (Methionine) of the 234th amino acid sequence of the cyclodextrin glucanotransferase (Accesion No. AY478421). Threonine), the 259th amino acid sequence from phenylalanine (Phenylalanine) to isoleucine (Isoleucine), and the 591th amino acid sequence from cyclone (Methionine) to alanine (Cylodextrin glucanotransferase) Specifically, it may be a cyclodextrin glucanotransferase of SEQ ID NO: 6, and preferably a cyclodextrin glucanotransferase encoded by the polyneutrophilide described in FIG. 9 and SEQ ID NO: 5.
상기 인테그레이션 부위(integration site)는 δ시퀀스(δsequence)일 수 있 으며, 바람직하게는 서열번호 7의 서열을 가지는 폴리뉴클레오타이드일 수 있다.The integration site may be a δ sequence, preferably a polynucleotide having a sequence of SEQ ID NO.
상기 형질전환 효모 제조용 벡터는 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자를 프로모터와 표면발현 염기서열이 포함된 벡터에 삽임함으로써 제조할 수 있다.The transformed yeast production vector may be prepared by inserting the cyclodextrin glucanotransferase gene into a vector including a promoter and a surface expression sequence.
보다 상세하게는,More specifically,
a) 싸이클로덱스트린 글루카노트랜스퍼레이즈를 수득하는 단계;a) obtaining a cyclodextrin glucanotransferase;
b) 상기 a) 단계에서 수득한 싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면발현용 벡터에 삽입하여 제1벡터를 제조하는 단계;b) preparing a first vector by inserting the cyclodextrin glucanotransferase obtained in step a) into a surface expression vector;
c) 상기 b) 단계에서 제조한 제1벡터에 숙주생물의 염색체에 외래 유전자를 삽입시키기 위한 염기서열을 삽입시키는 단계를 c) inserting a nucleotide sequence for inserting a foreign gene into the chromosome of the host organism into the first vector prepared in step b);
포함하는 형질전환 효모 제조용 벡터 제조방법에 의해 제조될 수 있다.It can be prepared by a vector production method for producing a transformed yeast comprising.
구체적으로, 상기 a) 단계는 pR2CGT[3-18](Protein Eng . Des . Sel ., 17, pp 205-211(2004))를 주형으로 하여 싸이클로덱스트린 글루카노트랜스퍼레이즈를 코딩하는 폴리뉴클레오타이드를 증폭시키는 방법으로 수행할 수 있다. 상기 pR2CGT[3-18]의 싸이클로덱스트린 글루카노트랜스퍼레이즈를 코딩하는 폴리뉴클레오타이드의 증폭은 중합효소연쇄반응(PCR amplification)을 이용하여 수행할 수 있으며, 상기 중합효소연쇄반응으로 증폭된 싸이클로덱스트린 글루카노트랜스퍼레이즈를 코딩하는 폴리뉴클레오타이드는 양 말단에 제한효소 절단 부위(restriction enzyme cutting site)을 포함할 수 있다. 상기 제한효소는 KpnI 또는 XhoI일 수 있다. 싸 이클로덱스트린 글루카노트랜스퍼레이즈를 코딩하는 폴리뉴클레오타이드는 바람직하게는 서열번호 6의 단백질을 코딩하는 폴리뉴클레오타이드일 수 있고, 더욱 바람직하게는 서열번호 5의 폴리뉴클레오타이드일 수 있다.Specifically, step a) is pR 2 CGT [3-18] ( Protein Eng . Des . Sel . , 17, pp 205-211 (2004)) as a template can be carried out by a method for amplifying a polynucleotide encoding a cyclodextrin glucanotransferase. Amplification of the polynucleotide encoding the cyclodextrin glucanotransferase of pR 2 CGT [3-18] can be performed using PCR amplification, and the cyclodextrin amplified by the polymerase chain reaction. The polynucleotide encoding the glucanotransferase may include a restriction enzyme cutting site at both ends. The restriction enzyme may be Kpn I or Xho I. The polynucleotide encoding the cyclodextrin glucanotransferase may preferably be a polynucleotide encoding the protein of SEQ ID NO: 6, more preferably the polynucleotide of SEQ ID NO: 5.
상기 중합효소연쇄반응을 수행하기 위한 프라이머는 일 예로 서열번호 1 및 서열번호 2일 수 있다.Primers for performing the polymerase chain reaction may be SEQ ID NO: 1 and SEQ ID NO: 2, for example.
상기 b) 단계의 상기 표면발현용 벡터는 바람직하게는 pYD1(Invitrogen, Carlsbad, CA, USA)일 수 있고, 상기 b) 단계는 상기 수득한 싸이클로덱스트린 글루카노트랜스퍼레이즈를 KpnI와 XhoI으로 처리한 pYD1에 삽입하는 방법으로 수행할 수 있다.The surface expression vector of step b) may preferably be pYD1 (Invitrogen, Carlsbad, CA, USA), and step b) may be performed by treating the obtained cyclodextrin glucanotransferase with Kpn I and Xho I. This can be done by inserting into one pYD1.
상기 제1벡터도 효모의 표면에 싸이클로덱스트린 글루카노트랜스퍼레이즈를 발현시키기 위한 형질전환 효모 제조용 벡터로 사용될 수 있으나, 보다 안정적이고 지속적인 효소의 발현을 위하여, 상기 제1벡터에 숙주생물의 염색체에 외래 유전자를 삽입시키기 위한 염기서열을 더욱 삽입시킬 수 있다.The first vector may also be used as a vector for preparing a transformed yeast for expressing cyclodextrin glucanotransferase on the surface of the yeast, but in order to express more stable and sustained enzyme, the first vector is foreign to the chromosome of the host organism. The base sequence for inserting the gene can be further inserted.
상기 c) 단계는 상기 제1벡터를 증폭시킨 후에, 제한효소로 처리하고, 상기 숙주생물의 염색체에 외래 유전자를 삽입시키기 위한 염기서열을 삽입하는 방법으로 수행할 수 있다. 상기 제1벡터의 증폭은 중합효소연쇄반응을 이용하여 수행할 수 있고, 상기 제한효소의 처리는 바람직하게는 SacI으로 처리할 수 있다. 상기 숙주생물의 염색체에 외래 유전자를 삽입시키기 위한 염기서열, 구체적으로 상기 효묘의 게놈에 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자를 병합가능하도록 인테그레이션(integration)하는 염기서열은 인테그레이션(integration) 벡터인 pδ Neo(Biotechol. Bioeng . 49, pp45-51(1996))를 제한효소 처리를 하여 수득할 수 있으며, 상기 제한효소는 바람직하게는 SacI일 수 있다. 또한, 상기 중합효소연쇄반응을 수행하기 위한 프라이머는 일 예로 서열번호 3 및 서열번호 4일 수 있다. 상기 숙주생물의 염색체에 외래 유전자를 삽입시키기 위한 염기서열은 인테그레이션 부위(integration site)일 수 있으며, 바람직하게는 δ시퀀스(δsequence)일 수 있고, 더욱 바람직하게는 pδNeo(Biotechol . Bioeng . 49, pp45-51(1996))로부터 수득한 것일 수 있으며, 가장 바람직하게는 서열번호 7의 서열을 가지는 폴리뉴클레오타이드일 수 있다.Step c) may be performed by amplifying the first vector, treating with a restriction enzyme, and inserting a nucleotide sequence for inserting a foreign gene into the chromosome of the host organism. Amplification of the first vector may be performed using a polymerase chain reaction, and the restriction enzyme may be treated with Sac I. A base sequence for inserting a foreign gene into the chromosome of the host organism, specifically, a base sequence for integrating the cyclodextrin glucanotransferase gene into the genome of the yeast seed, is integrated into the pδ Neo (integration) vector. Biotechol. Bioeng . 49, pp 45-51 (1996)) can be obtained by restriction enzyme treatment, which restriction enzyme may preferably be Sac I. In addition, primers for performing the polymerase chain reaction may be, for example, SEQ ID NO: 3 and SEQ ID NO: 4. The base sequence for inserting a foreign gene into the chromosome of the host organism may be an integration site, preferably a δ sequence, and more preferably pδNeo ( Biotechol . Bioeng . 49, pp45). -51 (1996)), and most preferably, may be a polynucleotide having a sequence of SEQ ID NO: 7.
상기 제조된 형질전환 효모 제조용 벡터는 일 예로 pδCGT[3-18]-2 또는 pδCGT[3-18]일 수 있다.The prepared vector for producing a transformed yeast may be, for example, pδCGT [3-18] -2 or pδCGT [3-18].
본 발명은 싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면에 발현하여 전분의 노화를 억제할 수 있는 형질전환 효모에 관한 것이다.The present invention relates to a transformed yeast capable of inhibiting aging of starch by expressing cyclodextrin glucanotransferase on the surface.
본 발명의 형질전환 효모는 표면에 싸이클로덱스트린 글루카노트랜스퍼레이즈를 안정적이고 지속적으로 발현함으로써, 호화된 전분의 노화를 억제할 수 있으므로, 상기 형질전환 효모를 사용하는 경우, 전분을 포함하는 식품의 품질을 향상시키고, 제품의 유통기한을 연장시킬 수 있는 우수한 효과가 있다.The transformed yeast of the present invention can stably and continuously express cyclodextrin glucanotransferase on the surface, thereby inhibiting the aging of gelatinized starch, and therefore, when using the transformed yeast, the quality of food containing starch It has an excellent effect that can improve the, and extend the shelf life of the product.
상기 형질전환 효모는 재조합 발현벡터를 숙주 생물에 도입시켜 형질전환 시킨 것일 수 있다. 상기 재조합 발현벡터는 싸이클로덱스트린 글루카노트랜스퍼레이즈, 프로모터 및 인테그레이션 부위(integration site)을 포함하는 형질전환 효모 제조용 벡터일 수 있으며, 바람직하게는 싸이클로덱스트린 글루카노트랜스퍼레 이즈를 삽입시킨 pYD1에 추가로 상기 숙주생물의 염색체에 외래 유전자를 삽입시키기 위한 염기서열을 삽입시킨 것일 수 있으며, 상기 숙주생물의 염색체에 외래 유전자를 삽입시키기 위한 염기서열은 pδNeo일 수 있다. The transformed yeast may be transformed by introducing a recombinant expression vector into a host organism. The recombinant expression vector may be a vector for preparing a transformed yeast comprising a cyclodextrin glucanotransferase, a promoter and an integration site, preferably in addition to pYD1 into which the cyclodextrin glucanotransferase is inserted. The base sequence for inserting the foreign gene into the chromosome of the host organism may be inserted, and the base sequence for inserting the foreign gene into the chromosome of the host organism may be pδNeo.
상기 재조합 발현벡터는 더욱 바람직하게는 전분의 노화억제에 효과가 있는 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자, 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자의 상부에 작동가능하게 연결된 프로모터 및 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈 유전자가 효모의 게놈에 병합가능하도록 인테그레이션하는 인테그레이션 부위(integration site) 즉, 인테그레이션 폴리뉴클레오타이드 서열을 포함하며, 상기 싸이클로덱스트린 글루카토트랜스퍼레이즈가 효모의 세포표면에 발현되는 것을 특징으로 하는 형질전환 효모 제조용 벡터일 수 있고, 일 예로, pδCGT[3-18]-2 또는 pδCGT[3-18]일 수 있다.The recombinant expression vector is more preferably a cyclodextrin glucanotransferase gene that is effective in inhibiting aging of starch, a promoter operably linked to an upper portion of the cyclodextrin glucanotransferase gene, and the cyclodextrin glucanotransferase gene. Vector comprising an integration site, ie, an integration polynucleotide sequence, which integrates so as to be able to integrate into the genome of the yeast, and wherein the cyclodextrin glutatotransferase is expressed on the cell surface of the yeast. Or, for example, pδCGT [3-18] -2 or pδCGT [3-18].
상기 숙주 생물은 효모일 수 있고, 바람직하게는 사카로마이세스 세르비지에(Saccharomyces cerevisiae), 사카로마이세스 로제이 (Saccharomyces rosei), 사카로마이세스 우바륨(Saccharomyces uvarum), 사카로마이세스 시바리에리(Saccharomyces chevalieri), 사카로마이세스 토루라스포라 델브루키(Torulaspora delbrueckii) 또는 클루베로마이세스 서모토러런스(Kluyveromyces thermotolerans)일 수 있고, 더욱 바람직하게는 사카로마이세스 세르비지에일 수 있다. 일 예로 상기 숙주 생물은 사카로마이세스 세르비지에 EBY100(Saccharomyces cerevisiae EBY100)일 수 있다. The host organism may be a yeast, preferably Saccharomyces cerevisiae , Saccharomyces rose rosei ), Saccharomyces uvarum ), Saccharomyces chevalieri , Saccharomyces Torulaspora delbrueckii or Kluyveromyces thermotolerans ), and more preferably Saccharomyces cerbizi . For example, the host organism is Saccharomyces servizier EBY100 ( Saccharomyces cerevisiae EBY100).
구체적으로, 상기 형질전환 효모는 사카로마이세스 세르비지에 EBY100(Saccharomyces cerevisiae EBY100)의 염색체에 pδCGT를 도입된 것일 수 있다. 상기 형질전환 효모의 제조는 pδCGT를 SalI으로 처리하여, 사카로마이세스 세르비지에 EBY100의 유전자에 도입시키는 방법으로 수행할 수 있다(J. Agric. Food Chem. 55, pp 4735-4740(2007)). 상기 문헌에 기재된 모든 내용은 본 명세서에 참조로써 포함된다. 상기 사카로마이세스 세르비지에 EBY100에 pδCGT를 도입시켜 형질전환시킨 효모는 트립토판이 결여된 YNB 배지[0.67% yeast nitrogen base without amino acid (YNB; Sigma Aldrich, St. Louis, MO, USA), 0.19% yeast synthetic drop-out medium supplement without tryptophan (YNB; Sigma Aldrich, St. Louis, MO, USA), 2% galactose, 1% starch, and 1.5% agar]를 이용하여 선별할 수 있으며, 상기 방법에 의해 선별된 형질전환 효모를 S. cerevisiae/pδCGT로 명명하였다. 상기 S. cerevisiae/pδCGT는 2007년 1 월 5 일 대한민국 대전광역시 유성구 어은동 52번지에 위치한 한국생명공학연구원에 기탁하였고, 2007년 1 월 11 일 기탁번호 KCTC 11060BP를 부여받았다. Specifically, the transgenic yeast is Saccharomyces cerevisiae E. Saccharomyces cerevisiae PδCGT may be introduced into the chromosome of EBY100). The production of the transformed yeast can be carried out by treating pδCGT with Sal I and introducing the gene of EBY100 into Saccharomyces cerbiz (J. Agric. Food Chem. 55, pp 4735-4740 (2007). )). All content set forth in this document is incorporated herein by reference. The yeast transformed by introducing pδCGT to EBY100 in Saccharomyces cervage was YNB medium lacking tryptophan [0.67% yeast nitrogen base without amino acid (YNB; Sigma Aldrich, St. Louis, MO, USA), 0.19 % yeast synthetic drop-out medium supplement without tryptophan (YNB; Sigma Aldrich, St. Louis, MO, USA), 2% galactose, 1% starch, and 1.5% agar]. The selected transformed yeast was named S. cerevisiae / pδCGT. The S. cerevisiae / pδCGT was deposited at the Korea Research Institute of Bioscience and Biotechnology, located at 52, Eui-dong, Yuseong-gu, Daejeon, Korea on January 5, 2007, and received the accession number KCTC 11060BP on January 11, 2007.
본 발명은 상기 전분의 노화억제에 효과가 있는 싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면에 안정적이고 지속적으로 발현하는 효모를 이용하여 제조되는 전분 포함 식품 제조용 반죽에 관한 것이다. 상기 전분 포함 식품 제조용 반죽은 은 바람직하게는 빵 반죽 또는 증편 반죽에 관한 것이다.The present invention relates to a starch-containing food dough prepared using yeast that stably and continuously expresses the cyclodextrin glucanotransferase effective on the aging of the starch. The starch-containing dough for food production preferably relates to bread dough or thickened dough.
또한, 본 발명은 상기 전분 포함 식품 제조용 반죽을 이용하여 제조한 전분 포함 식품에 관한 것이다. 상기 전분 포함 식품은 바람직하게는 빵 또는 증편일 수 있다.The present invention also relates to a starch-containing food prepared using the starch-containing food preparation dough. The food containing starch may preferably be bread or thickening.
본 발명은 상기 전분의 노화억제에 효과가 있는 싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면에 안정적이고 지속적으로 발현하는 효모를 이용하여 전분 포함 식품을 제조하는 방법에 관한 것이다. 상기 전분 포함 식품은 바람직하게는 빵 또는 증편일 수 있다.The present invention relates to a method for preparing starch-containing foods using yeast that stably and continuously expresses cyclodextrin glucanotransferase, which is effective in inhibiting aging of the starch. The food containing starch may preferably be bread or thickening.
상기 전분 포함 식품을 제조방법은 전분 포함 식품 제조용 반죽을 제조하는 단계 및 전분 포함 식품을 제조하는 단계를 포함하는 것으로, 통상의 전분 포함 식품 제조 방법, 구체적으로는 빵 제조방법 또는 증편 제조방법에 의할 수 있다.The method for preparing a food containing starch comprises the steps of preparing a dough for preparing food containing starch and preparing a food containing starch. can do.
일 예로 상기 빵을 제조하는 방법은For example, the method of manufacturing the bread
a) 빵 반죽을 제조하는 단계; 및a) preparing a bread dough; And
b) 상기 a) 단계의 빵 반죽에 열을 가하여 빵을 제조하는 단계b) preparing bread by applying heat to the bread dough of step a)
를 포함하는 빵 제조방법일 수 있다.It may be a bread manufacturing method comprising a.
상기 a) 단계는 전분 가루를 포함하는 곡물가루, 물, 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면에 안정적이고 지속적으로 발현하는 효모, 추가 반죽 성분 및 첨가물을 혼합하여 제조할 수 있다. 상기 곡물가루는 바람직하게는 밀가루일 수 있다.Step a) may be prepared by mixing the flour, water containing starch powder, yeast expressing the cyclodextrin glucanotransferase stably and continuously on the surface, additional dough ingredients and additives. The grain flour may be preferably wheat flour.
상기 추가 반죽 성분은 설탕, 소금, 지방 또는 오일, 다이어트 식이 성분, 우유 또는 우유 분말, 글루텐 등으로 이루어진 군에서 선택된 1 이상일 수 있다.The additional dough component may be one or more selected from the group consisting of sugar, salt, fat or oil, diet dietary ingredients, milk or milk powder, gluten and the like.
상기 첨가물은 유화제, 향미료, 산화제, 미네랄, 비타민, 하이드로콜로이드 또는 효소 등으로 이루어진 군에서 선택된 1 이상일 수 있다. The additive may be at least one selected from the group consisting of emulsifiers, flavors, oxidizing agents, minerals, vitamins, hydrocolloids or enzymes.
상기 유화제는 반죽 강화 및 빵 속을 부드럽게 하기 위하여 첨가되는 것으 로, 레시틴, 폴리에틸렌 스테아르산염, 식용 지방산인 모노글리세라이드 또는 디글리세라이드, 식용 지방산의 아세트산 에스테르, 식용 지방산의 디아세틸 타르타르산 에스테르, 식용 지방산의 수크로스 에스테르, 나트륨 스테아로일-2-락틸레이트 또는 칼슘 스테아로일-2-락틸레이트일 수 있다.The emulsifier is added to strengthen the dough and soften the bread, lecithin, polyethylene stearate, edible fatty acid monoglyceride or diglyceride, acetic acid ester of edible fatty acid, diacetyl tartaric acid ester of edible fatty acid, edible fatty acid Sucrose ester, sodium stearoyl-2-lactylate or calcium stearoyl-2-lactylate.
상기 효소는 글루코스 산화효소 또는 아스코르베이트 산화효소 등의 산화환원효소, 리파아제 같은 가수분해효소, 알파-아밀라제 같은 글루코시다제 또는 에스테라제일 수 있다.The enzyme may be an oxidoreductase such as glucose oxidase or ascorbate oxidase, a hydrolase such as lipase, a glucosidase such as alpha-amylase or an esterase.
본 발명에 따른 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면에 안정적이고 지속적으로 발현하는 효모의 첨가량은 건체 중량을 기준으로 상기 곡물 가루 1kg 당 0.5 g 내지 50 g, 바람직하게 1 g 내지 30 g, 더욱 바람직하게는 5 g 내지 20 g, 가장 바람직하게는 7.5 g 내지 12.5 g일 수 있으며, 구체적으로 곡물가루, 물 및 효모의 첨가량은 상기 곡물가루 100 g을 기준으로 물 30 ml 내지 80 ml, 바람직하게는 50 ml 내지 75 ml 및 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면에 안정적이고 지속적으로 발현하는 효모 0.5 g 내지 2 g, 바람직하게는 0.75 g 내지 1.25 g, 더욱 바람직하게는 0.9 g 내지 1.1 g 일 수 있다. The amount of yeast that stably and continuously expresses the cyclodextrin glucanotransferase according to the present invention on the surface is 0.5 g to 50 g, preferably 1 g to 30 g, more preferably 1 kg to 1 kg of the grain flour based on dry weight. Preferably from 5 g to 20 g, most preferably from 7.5 g to 12.5 g, specifically the amount of grain flour, water and yeast added is 30 ml to 80 ml, preferably based on 100 g of the grain flour. 50 g to 75 ml and yeast 0.5 g to 2 g, preferably 0.75 g to 1.25 g, more preferably 0.9 g to 1.1 g, which stably and continuously express the cyclodextrin glucanotransferase on the surface. .
상기 b) 단계는 상기 a) 단계에서 제조한 빵 반죽에 열을 가하는 방법으로 수행할 수 있으며, 통상의 오븐 등을 이용하여 빵 반죽에 열을 가하여 빵을 제조하는 방법으로 수행할 수 있다.The step b) may be performed by applying heat to the bread dough prepared in step a), and may be performed by applying heat to the bread dough using a conventional oven to prepare bread.
상기 열을 가하여 빵을 제조하는 방법을 일 예로, 상기 수득한 빵 반죽을 생지 분할한 후, 10 ℃ 내지 40℃, 바람직하게는 18℃ 내지 30℃ 및 상대습도 60 % 내지 95 %, 바람직하게는 70 % 내지 90 %의 조건에서 1 시간 내지 10 시간, 바람직하게는 2 시간 내지 4 시간 동안 1차 발효시키고, 성형한 후에 15 ℃ 내지 35 ℃, 바람직하게는 20 ℃ 내지 30 ℃ 및 상대습도 65 % 내지 95 %, 바람직하게는 70 % 내지 90 %의 조건에서 30 분 내지 5 시간, 바람직하게는 1 시간 내지 3 시간 동안 2차 발효시킨 다음 150 ℃ 내지 250 ℃, 바람직하게는 170 ℃ 내지 230 ℃, 더욱 바람직하게는 170 ℃ 내지 230 ℃의 오븐에서 10 분 내지 180분, 바람직하게는 30 분 내지 90 분 동안 구워서 제조할 수 있다. For example, a method of manufacturing bread by applying the heat, and after dividing the obtained bread dough, 10 ℃ to 40 ℃, preferably 18 ℃ to 30 ℃ and
일 예로, 본 발명의 증편의 제조는 곡물가루, 반죽 성분 및 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면에 안정적이고 지속적으로 발현하는 효모 또는 추가로 첨가물 등을 첨가하여 증편 반죽을 제조하고, 상기 증편 반죽을 발효시킨 후, 성형한 다음 쪄서(streaming) 제조하는 방법으로 수행할 수 있다.For example, the preparation of the thickener of the present invention is to produce a thickening dough by adding grain flour, dough components and yeast or additional additives that stably and continuously express the cyclodextrin glucanotransferase on the surface, and the thickening dough After fermentation, it may be molded and then streamed.
상기 곡물가루는 바람직하게는 쌀가루일 수 있고, 상기 추가 반죽 성분은 설탕, 소금, 다이어트 식이성분 등일 수 있다. 또한, 상기 첨가물은 유화제, 향미료, 산화제, 미라, 비타민, 하이드로콜로이드 또는 효소 등으로 이루어진 군에서 선택된 1 이상일 수 있다. The grain flour may preferably be rice flour, and the additional dough component may be sugar, salt, diet dietary ingredients, and the like. In addition, the additive may be at least one selected from the group consisting of emulsifiers, flavors, oxidizing agents, mummies, vitamins, hydrocolloids or enzymes.
상기 증편 반죽의 발효는 20 ℃ 내지 50 ℃, 바람직하게는 30 ℃ 내지 40 ℃의 조건에서 1 시간 내지 10 시간, 바람직하게는 2 시간 내지 5 시간 동안 발효시키는 방법으로 수행할 수 있다.Fermentation of the thickening dough may be carried out by a method of fermentation for 1 hour to 10 hours, preferably 2 hours to 5 hours at 20 ℃ to 50 ℃, preferably 30 ℃ to 40 ℃ conditions.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of examples. However, the following examples are merely to illustrate the invention, the present invention is not limited by the following examples.
<< 실시예Example >>
<< 실시예Example 1> 재조합 효모의 제조 1> Preparation of Recombinant Yeast
싸이클로덱스트린 글루카노트랜스퍼레이즈를 표면에 안정적이고 지속적으로 발현하는 재조합 효모를 제조하기 위하여, 각각 싸이클로덱스트린 글루카노트랜스퍼레이즈, 프로모터 및 인테그레이션 부위를 포함하는 염기서열을 가지는 부위를 삽입시킬 수 있으며, 상기 재조합 효모의 제조방법은 도 1과 같다.In order to prepare a recombinant yeast that stably and continuously expresses the cyclodextrin glucanotransferase on the surface, a site having a nucleotide sequence including a cyclodextrin glucanotransferase, a promoter and an integration site may be inserted, and the recombinant Yeast manufacturing method is the same as FIG.
상기 도 1의 제조방법은 상세하게는 하기와 같다.The manufacturing method of FIG. 1 is as follows.
실시예Example 1-1 1-1 싸이클로덱스트린Cyclodextrin 글루카노트랜스퍼레이즈의Glucanotransferase 수득 purchase
싸이클로덱스트린 글루카노트랜스퍼레이즈를 수득하기 위하여, CGTase[3-18]을 코딩하는 유전자를 포함하는 pR2CGT [3-18](Protein Eng . Des . Sel ., 17, pp 205-211(2004))를 주형(template)으로 하여 중합효소연쇄반응을 수행하였다. 상기 중합효소연쇄반응은 하기 표 1의 프라이머를 이용하였고, 하기 표 2의 PCR용 조성물의 조성비와 하기 표 3의 PCR 조건으로 PCR을 수행하였다. 하기 표 1의 서열번호 1의 프라이머 및 서열번호 2의 프라이머는 제한효소인 KpnI 또는 XhoI의 제한효소 절단 부위를 가지고 있다. 하기 표 2에 기재된 중합효소(ExTaq polymerase)는 Takara(일본)로부터 구입하여 사용하였다.Cyclo dextrin glue Kano in order to obtain a transfer-raised, pR 2 CGT [3-18] which includes the gene encoding the CGTase [3-18] (Protein Eng . Des . Sel . , 17, pp 205-211 (2004)) was used as a template to conduct a polymerase chain reaction. The polymerase chain reaction was performed using the primers of Table 1, PCR was carried out in the composition ratio of the PCR composition of Table 2 and the PCR conditions of Table 3 below. The primers of SEQ ID NO: 1 and SEQ ID NO: 2 of Table 1 have restriction enzyme cleavage sites of restriction enzymes Kpn I or Xho I. The polymerase (ExTaq polymerase) described in Table 2 below was purchased from Takara (Japan) and used.
실시예Example 1-2 재조합 벡터 및 재조합 효모의 제조 1-2 Preparation of Recombinant Vectors and Recombinant Yeast
상기 재조합 벡터를 제조하기 위하여, 상기 실시예 1-1에서 수득한 싸이클로덱스트린 글루카노트랜스퍼레이즈를 상용화된 표면발현용 벡터 pYD1(Invitrogen, Carlsbad, CA, USA)와 재조합 하여 pYCGT[3-18]을 제조하였다. 보다 구체적으로는 상기 벡터 pYD1를 제한효소 KpnI(Takara, 일본) 및 XhoI(Takara, 일본)으로 처리하고, 상기 제한효소 처리한 벡터 pYD1에 상기 실시예 1-1에서 수득한 싸이클로덱스트린 글루카노트랜스퍼레이즈를 삽입하여 재조합 벡터인 pYCGT[3-18]를 제조하였다.To prepare the recombinant vector, the cyclodextrin glucanotransferase obtained in Example 1-1 was recombined with a commercially available surface expression vector pYD1 (Invitrogen, Carlsbad, CA, USA) to obtain pYCGT [3-18]. Prepared. More specifically, the restriction enzyme the vector pYD1 Kpn I (Takara, Japan) and Xho I (Takara, Japan) to the process, and the restriction enzyme treated vector pYD1 a cycle dextrin glue obtained in the above Examples 1-1 Kano The transferase was inserted to prepare recombinant vector pYCGT [3-18].
보다 안정적이고 지속적인 효소의 발현을 위하여, 상기 재조합 벡터인 pYCGT[3-18]를 직접 사용하지 아니하고, pYCGT[3-18]의 표면발현 관련 주요부위인 GAL1 프로모터와 TRP1 유전자 부위 사이에 인테그레이션(integration) 벡터인 pδNeo(Biotechol. Bioeng . 49, pp 45-51(1996))를 삽입하여 pδCGT를 완성하였다.For more stable and sustained expression of enzymes, the integration between the GAL1 promoter and the TRP1 gene region, which is a key site related to the surface expression of pYCGT [3-18], is not used directly, and the recombinant vector pYCGT [3-18] is used. ) PδNeo ( Biotechol. Bioeng . 49, pp 45-51 (1996)) was inserted to complete pδCGT.
구체적으로 상기 pYCGT[3-18]의 싸이클로덱스트린 글루카노트랜스퍼레이즈 및 GAL1 프로모터 부위를 수득하기 위하여, pYCGT[3-18]를 주형으로 하고, 하기 표 4의 서열번호 3 및 서열번호 4의 프라이머를 이용하여 상기 표 2의 PCR용 조성물의 조성비와 상기 표 3의 PCR 조건으로 중합효소연쇄반응을 수행하였다. 다만, 상기 표 2와 달리 프라이머를 서열번호 1 및 서열번호 2의 프라이머가 아닌 서열번호 3 및 서열번호 4의 프라이머를 사용하였다. 하기 표 4의 서열번호 3의 프라이머 및 서열번호 4의 프라이머는 제한효소인 SacI의 제한효소 절단 부위를 가지고 있다. Specifically, in order to obtain the cyclodextrin glucanotransferase and the GAL1 promoter region of pYCGT [3-18], pYCGT [3-18] was used as a template, and the primers of SEQ ID NO: 3 and SEQ ID NO: 4 of Table 4 below were used. The polymerase chain reaction was carried out using the composition ratio of the PCR composition of Table 2 and the PCR conditions of Table 3. However, unlike Table 2, primers of SEQ ID NO: 3 and SEQ ID NO: 4 were used instead of the primers of SEQ ID NO: 1 and SEQ ID NO: 2. The primers of SEQ ID NO: 3 and the primers of SEQ ID NO: 4 of the following Table 4 have restriction enzyme cleavage sites of restriction enzyme Sac I.
상기 중합효소연쇄반응에 의해 수득한 4.2 kb의 상기 pYCGT[3-18]의 싸이클로덱스트린 글루카노트랜스퍼레이즈 및 GAL1 프로모터 부위를 제한효소인 SacI(Takara, 일본)으로 처리한 상기 인테그레이션(integration) 벡터인 pδNeo에 삽입하여, 재조합 벡터를 제조하였으며, 상기 방법에 의해 제조된 재조합 벡터를 pδCGT이라고 명하였다.The integration vector of 4.2 kb of pYCGT [3-18] cyclodextrin glucanotransferase and GAL1 promoter site obtained by the polymerase chain reaction was treated with restriction enzyme Sac I (Takara, Japan). The recombinant vector was prepared by inserting into pδNeo, and the recombinant vector prepared by the above method was named pδCGT.
한편, 본 발명의 재조합 벡터로 형질전화시킨 효모의 유용성을 확인하기 위하여, 대조예로 본 발명과 달리 싸이클로덱스트린 글루카노트랜스퍼레이즈을 포함하고 있지 아니한 재조합 벡터를 제조하였다. 구체적으로 상기 pδCGT와 달리, 주형 DNA로 pYD1를 이용하고 중합효소연쇄반응을 수행하여 2.1 kb의 DNA fragment를 수득한 것을 제외하고는 상기 pδCGT와 동일한 방법으로 제조하였으며, 상기 방법에 의해 제조된 재조합 벡터를 pδYD1이라고 명하였다.On the other hand, in order to confirm the usefulness of the yeast transformed with the recombinant vector of the present invention, a recombinant vector was prepared that does not contain cyclodextrin glucanotransferase as a control example, unlike the present invention. Specifically, unlike pδCGT, except that a 2.1 kb DNA fragment was obtained by using pYD1 as a template DNA and performing a polymerase chain reaction, the recombinant vector prepared by the above method was prepared. Was designated as pδYD1.
상기 제조된 재조합 벡터인 pδCGT와 pδYD1를 E. coli DH5α에 형질전환시키고, 37 ℃의 조건 및 암피실린(ampicillin, 100 μg/ml)이 첨가된 LB 배지(1% bacto-tryptone, 0.5% yeast extract, 0.5% NaCl)에서 배양한 후에, alkali-cation kit(Bio101, USA)을 이용하여 제조사의 사용법(manufacurer's protocol)에 따라 효모에 형질전환시켰다. 상기 재조합 효모를 제조하기 위하여 형질전환의 대상이 된 숙주생물은 S. cerevisiae EBY100(Invitrogen, USA)을 사용하였다. 상기 형질전환시킨 효모 중에서 상기 벡터가 안정적으로 발현되는 효모를 선별하기 위하여, 트립토판이 결여된 YNB 배지[0.67% yeast nitrogen base without amino acid (YNB; Sigma Aldrich, St. Louis, MO, USA), 0.19% yeast synthetic drop-out medium supplement without tryptophan (YNB; Sigma Aldrich, St. Louis, MO, USA), 2% galactose, 1% starch, and 1.5% agar]를 이용하여 형질전환시킨 효모를 배양하였으며, 이 중 상기 싸이클로덱스트린 글루카노트랜스퍼레이즈가 안정적으로 배양되는 것으로 확인된 효모를 선별하여 S. cerevisiae/pδCGT라 명명하였고, 대조예로 재조합 벡터가 형질전환된 것으로 확인된 효모를 선별하여 S. cerevisiae/pδYD1라 명명하였다 The recombinant vectors pδCGT and pδYD1 prepared above were transformed into E. coli DH5α, and LB medium (1% bacto-tryptone, 0.5% yeast extract, added with ampicillin (100 μg / ml) at 37 ° C. After incubation in 0.5% NaCl, yeast were transformed using an alkali-cation kit (Bio101, USA) according to the manufacturer's instructions (manufacurer's protocol). S. cerevisiae EBY100 (Invitrogen, USA) was used as a host organism to be transformed to produce the recombinant yeast. In order to screen the yeast stably expressing the vector among the transformed yeast, YNB medium lacking tryptophan [0.67% yeast nitrogen base without amino acid (YNB; Sigma Aldrich, St. Louis, MO, USA), 0.19 % yeast synthetic drop-out medium supplement without tryptophan (YNB; Sigma Aldrich, St. Louis, MO, USA), 2% galactose, 1% starch, and 1.5% agar]. Among the yeast confirmed that the cyclodextrin glucanotransferase was stably cultured, was selected as S. cerevisiae / pδCGT, and as a control, the yeast identified as transformed with the recombinant vector was selected as S. cerevisiae / pδYD1. Named
상기 재조합 벡터로 형질전환시킨 재조합 효모의 효과를 확인하기 위하여, YNB 배지에서 배양된 재조합 효모를 YPG 배지(1 % yeast extract, 2 % peptone 및 2 % galactose)에서 25 ℃의 조건 및 200 rpm으로 진탕배양하였다.In order to confirm the effect of the recombinant yeast transformed with the recombinant vector, the recombinant yeast cultured in YNB medium was shaken at 200 rpm and 200 rpm in YPG medium (1% yeast extract, 2% peptone and 2% galactose) Incubated.
<< 실시예Example 2> 재조합 효모의 2> of recombinant yeast 냉해동Cold thaw 안정성 stability
재조합 효모의 냉해동 안정성을 확인하기 위하여, 흡광도계를 이용하여 600 nm의 파장에서 효모 균체 수를 측정하여 동일한 양의 S. cerevisiae EBY100와 상기 실시예 1에서 제조한 형질전환체인 S. cerevisiae/pδCGT를 각각 - 20 ℃에서 12 시간 냉동 보관한 후, 1시간 동안 27 ℃에서 해동하였다. 상기 해동한 균체를 10-7배로 희석한 후, YPD 고체 배지(2 % peptone, 1 % yeast extract, 2 % glucose, 및 1 % agar)에 30 ℃에서 60 시간 동안 배양하여 생존 균체수의 비율을 확인하였으며, 그 결과를 도 3에 나타내었다. In order to confirm the freeze thaw stability of the recombinant yeast, by measuring the number of yeast cells at a wavelength of 600 nm using an absorbometer, the same amount of S. cerevisiae EBY100 and the transformant S. cerevisiae / pδCGT prepared in Example 1 Were each stored frozen at -20 ° C for 12 hours and then thawed at 27 ° C for 1 hour. After diluting the thawed cells by 10 -7 times, incubated in YPD solid medium (2% peptone, 1% yeast extract, 2% glucose, and 1% agar) for 60 hours at 30 ℃ to determine the percentage of viable cells It confirmed, and the result is shown in FIG.
상기 도 3에 나타낸 바와 같이, 냉해동을 4회 반복하는 동안 S. cerevisiae/pδCGT의 경우 98%의 생존능을 보였으나, 야생형(wild type)인 S. cerevisiae EBY100는 78%의 생존능을 보여, 재조합 효모가 냉해동 안정성에서 매우 우수한 것으로 확인되었다.As shown in FIG. 3, S. cerevisiae / pδCGT showed 98% viability during cold thaw four times, but wild type S. cerevisiae EBY100 showed 78% viability. Yeast was found to be very good in freeze thaw stability.
<< 실시예Example 3> 재조합 효모를 이용한 빵 및 증편의 제조 3> Preparation of Bread and Jeungpyun Using Recombinant Yeast
3-1 빵의 제조3-1 Manufacturing of Bread
재조합 효모의 노화억제 효과를 확인하기 위하여, 재조합 효모를 이용하여 빵을 제조하였다. 보다 상세하게는, 제빵용 믹스(White Pan bread Mix II, CJ, 대한민국) 247 g과 물 173 ml을 혼합하고, 재조합 효모를 건조중량을 기준으로 2.5 g를 첨가한 후에, 제빵기에(SHB-600, Samsung Co., 대한민국) 넣어 제조하였다.In order to confirm the anti-aging effect of the recombinant yeast, bread was prepared using the recombinant yeast. More specifically, 247 g of white pan bread Mix II (CJ, South Korea) and 173 ml of water are mixed, and 2.5 g of the recombinant yeast is added based on dry weight, and then to the baking machine (SHB-600). , Samsung Co., South Korea) was prepared.
실험예의 경우, 재조합 효모로 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 S. cerevisiae/pδCGT를 이용하였고, 대조예의 경우 재조합 효모로 싸이클로덱스트린 글루카노트랜스퍼레이즈가 포함되지 아니한 pδYD1를 형질전환시킨 S. cerevisiae/pδYD1를 이용하였으며, 각각의 부피 증가비를 비교하였으며, 그 결과를 도 4에 나타내었다.If the experiment example, in which the recombinant yeast cyclo dextrin glue transfer Kano were raised the use of the S. cerevisiae / pδCGT expressed on the surface, for example the control transformed pδYD1 which are not containing the cyclo dextrin glue transfer Kano raised to the recombinant yeast S. cerevisiae / pδYD1 was used, and the ratio of each volume increase was compared, and the results are shown in FIG. 4.
상기 도 4에 나타낸 바와 같이, 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 S. cerevisiae/pδCGT를 이용한 경우에는 재조합 효모로 싸이클로덱스트린 글루카노트랜스퍼레이즈가 포함되지 아니한 pδYD1를 형질전환시킨 S. cerevisiae/pδYD1를 이용한 경우에 비하여 그 부피비가 25% 정도 증가하는 것으로 확인되었다. Wherein as shown in FIG. 4, cyclo dextrin glue Kano transfer case is raised by the S. cerevisiae / pδCGT expressed on the surface of S. was transformed pδYD1 which are not containing the cyclo dextrin glue transfer Kano raised to cerevisiae recombinant yeast / Compared with the case of using pδYD1, the volume ratio was confirmed to increase by about 25%.
상기한 결과로부터, 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 S. cerevisiae/pδCGT를 이용한 경우에는 통상적으로 추가 공정을 통해 노화억제 효소를 첨가한 경우와 같이, 전분의 노화 억제 효과가 있는 것으로 확인되었다.From the above results, when using S. cerevisiae / pδCGT expressing cyclodextrin glucanotransferase on the surface, it was confirmed that starch inhibits the aging of starch as in the case of adding an anti-aging enzyme through an additional process. It became.
3-2 증편의 제조3-2 Preparation of enlargement
재조합 효모의 노화억제 효과를 확인하기 위하여, 재조합 효모를 이용하여 증편을 제조하였다. 보다 상세하게는, 쌀가루 100 g, 설탕 15 g, 소금 1 g 및 재조합 효모를 건조중량을 기준으로 1.5 g을 혼합한 후, 35 ℃에서 4 시간 동안 발효시킨 후에, 15 g씩 덜어내어 증편틀(직경 25 mm, 높이 30 mm)에 넣어 30분 동안 쪄서(streaming) 제조하였다.In order to confirm the anti-aging effect of the recombinant yeast, Jeungpyun was prepared using the recombinant yeast. More specifically, 100 g of rice flour, 15 g of sugar, 1 g of salt, and recombinant yeast were mixed with 1.5 g based on dry weight, and then fermented at 35 ° C. for 4 hours. 25 mm,
실험예의 경우, 재조합 효모로 S. cerevisiae/pδCGT를 이용하였고, 대조예의 경우 재조합 효모로 S. cerevisiae/pδYD1를 이용하였으며, 각각의 부피 증가비를 비교하였고, 그 결과를 도 5에 나타내었다.In the experimental example, S. cerevisiae / pδCGT was used as the recombinant yeast, and S. cerevisiae / pδYD1 was used as the recombinant yeast, and the ratio of the volume increase was compared, and the results are shown in FIG. 5.
상기 도 5에 나타낸 바와 같이, 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 S. cerevisiae/pδCGT를 이용한 경우에는 재조합 효모로 싸이클로덱스트린 글루카노트랜스퍼레이즈가 포함되지 아니한 pδYD1를 형질전환시킨 S. cerevisiae/pδYD1를 이용한 경우에 비하여 그 부피비가 45% 정도 증가하는 것으로 확인되었다.Wherein as shown in FIG. 5, cyclo dextrin glue Kano transfer case is raised by the S. cerevisiae / pδCGT expressed on the surface of S. was transformed pδYD1 which are not containing the cyclo dextrin glue transfer Kano raised to cerevisiae recombinant yeast / Compared to the case of using pδYD1, the volume ratio was found to increase by 45%.
<< 실시예Example 4> 재조합 효모를 이용하여 제조한 빵 및 증편의 노화억제 효과 4> Anti-aging Effect of Bread and Jeungpyun Prepared Using Recombinant Yeast
재조합 효모를 이용하여 제조한 빵 및 증편의 노화억제효과를 측정하기 위하여 시차주사열량계를 이용하여 노화도를 측정하였다.Aging degree was measured using a differential scanning calorimeter to measure the aging inhibitory effect of bread and Jeungpyun prepared using recombinant yeast.
상세하게는 상기 실시예 3-1에서 제조한 빵과 상기 실시예 3-2에서 제조한 증편을 각각 비닐팩에 포장하여 4 ℃에서 냉장 보관하면서, 각각의 샘플 중 10 mg을 20 ℃ 내지 130 ℃의 범위에서 분당 5 ℃의 속도로 시차주사열량계(Differential Scanning Caloriemeter, DSC)를 이용하여 전분의 노화도를 측정하였으며, 빵의 노화도를 도 6에 나타내었고, 증편의 노화도를 도 7에 나타내었다. Specifically, the bread prepared in Example 3-1 and the thickener prepared in Example 3-2 were each packed in a plastic pack and refrigerated at 4 ° C., while 10 mg of each sample was stored at 20 ° C. to 130 ° C. The aging degree of starch was measured using a differential scanning caloriemeter (DSC) at a rate of 5 ° C. per minute in the range, the aging degree of bread is shown in FIG. 6, and the aging degree of thickening is shown in FIG. 7.
상기 도 6에 나타낸 바와 같이, 빵의 노화도의 측정은 냉장 보관 후, 3 일 및 7 일이 경과된 시점에서 수행하였고, 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 S. cerevisiae/pδCGT를 이용한 경우에는 재조합 효모로 싸이클로덱스트린 글루카노트랜스퍼레이즈가 포함되지 아니한 pδYD1를 형질전환시킨 S. cerevisiae/pδYD1를 이용한 경우에 비하여 현격한 노화의 감소를 보였고, 7 일이 경과한 시점에서는 대조예에 비하여 50 % 이하의 노화도를 보여 본 발명의 재조합 효모로 빵을 제조할 경우, 현격한 노화 감소 효과가 있음을 확인할 수 있었다.As shown in FIG. 6, the aging degree of bread was measured at 3 and 7 days after cold storage, and when S. cerevisiae / pδCGT expressing cyclodextrin glucanotransferase was expressed on the surface. Showed a significant decrease in aging compared to the case of using S. cerevisiae / pδYD1 transformed with pδYD1 without the cyclodextrin glucanotransferase with recombinant yeast, and 50% compared to the control at 7 days. When the bread is produced with the recombinant yeast of the present invention showing the following degree of aging, it was confirmed that there is a significant aging reduction effect.
또한, 상기 도 7에 나타낸 바와 같이, 증편의 노화도의 측정은 냉장 보관 후, 12 시간 및 24 시간이 경과된 시점에서 수행하였고, 대조예인 S. cerevisiae/pδYD1를 이용한 경우에 비하여 싸이클로덱스트린 글루카노트랜스퍼레이즈가 표면에 발현된 S. cerevisiae/pδCGT를 이용한 본원발명의 경우에 비하여 현저한 노화의 감소를 보였고, 24시간이 경과한 시점에서는 대조예에 비하여 30% 이하의 노화도를 보였으며 특히, 대조예의 12 시간이 경과한 시점의 노화도 보다 본 발명의 24시간이 경과한 시점의 노화도가 낮은 것으로 확인되어, 본 발명의 재조합 효모로 증편을 제조할 경우, 현격한 노화 감소 효과가 있음을 확인할 수 있었다.In addition, as shown in FIG. 7, the degree of aging of the enlargement was carried out after 12 hours and 24 hours after refrigerated storage, and compared to the case of using S. cerevisiae / pδYD1 as a control example, cyclodextrin glucanotransfer. In the present invention using the S. cerevisiae / pδCGT expressed on the surface, there was a marked decrease in aging, and after 24 hours, the aging degree was less than 30% compared to the control, especially, 12 of the control. It was confirmed that the aging degree at the time of 24 hours of the present invention is lower than the aging degree at the time elapsed time, and when producing the enlargement with the recombinant yeast of the present invention, it was confirmed that there is a significant aging reduction effect.
<< 실시예Example 5> 재조합 효모를 이용하여 제조한 빵의 5> of bread made using recombinant yeast 소당류Small sugars 분석 analysis
상기 실시예 3의 S. cerevisiae/pδCGT를 이용하여 제조한 빵 10 g을 증류수 100 ml에 넣고 1 시간 동안 상온에서 교반 후, 7,000 x g의 조건으로 10분 동안 원심분리하고, 상기 원심분리를 수행하여 수득한 상층액을 0.45㎛ 여과막으로 여과한 다음 고속액체크로마토그래피(HPLC, SLC-100, Samsung Electronics Inc., 대한민국)를 이용하여 소당류를 분석하였으며, 그 결과를 도 8에 나타내었다. 10 g of the bread prepared using S. cerevisiae / pδCGT of Example 3 was added to 100 ml of distilled water and stirred at room temperature for 1 hour, followed by centrifugation for 10 minutes under conditions of 7,000 xg, followed by centrifugation. The obtained supernatant was filtered with 0.45 μm filtration membrane, and then the small sugars were analyzed by high performance liquid chromatography (HPLC, SLC-100, Samsung Electronics Inc., Korea), and the results are shown in FIG. 8.
상기 도 8에 나타낸 바와 같이, 상기 실시예 3의 빵에는 주로 글루코오스, 말토오스, 및 말토트라이오스가 존재하는 것이 확인되었다. As shown in FIG. 8, it was confirmed that glucose, maltose, and maltotriose were mainly present in the bread of Example 3.
상기한 결과로부터, 본 발명의 재조합 효모에는 그 표면에 싸이클로덱스트린 글루카노트랜스퍼레이즈가 안정적이고 지속적으로 발현되므로, 글루코오스 등을 생산할 수 있는 것으로 확인되었고, 추가로 상기 재조합 효모를 이용한 빵의 제조 과정에서 유럽 등에서 첨가제로 사용이 허용되지 아니한 싸이클로덱스트린이 발생되지 아니하였으므로, 상기 재조합 효모를 산업 특히 식품산업 분야에 널리 사용될 수 있는 것으로 확인되었다. From the above results, it was confirmed that the recombinant yeast of the present invention can stably and continuously express cyclodextrin glucanotransferase on its surface, thereby producing glucose and the like, and further, in the process of manufacturing bread using the recombinant yeast. Since cyclodextrins, which are not allowed to be used as additives in Europe and the like, were not generated, it was confirmed that the recombinant yeast could be widely used in the industry, particularly in the food industry.
본 발명의 재조합 효모는 야생형 효모에 비하여 냉해동 안정성이 우수하여, 효모가 첨가된 전분을 포함한 반죽의 냉동 또는 냉장 보관 시 효모의 생존능이 우수하고, 야생형 효모에 비하여 제조된 제품의 부피 증가비가 높을 뿐만 아니라, 재조합 효모를 이용하여 제조한 빵 또는 증편의 경우 본 발명의 재조합 효모의 표면에 싸이클로덱스트린 글루카노트랜스퍼레이즈가 안정적이고 지속적으로 발현되므로, 전분이 포함되어 있는 빵 또는 증편 등의 전분 소재 가공 식품의 노화를 억제하여 전분이 포함된 식품의 품질을 향상시키고, 제품의 유통기한을 연장시킬 수 있어 산업적으로 특히, 식품 산업과 관련하여 그 유용성이 매우 크다 할 것이다.Recombinant yeast of the present invention is excellent in freezing thaw stability compared to wild-type yeast, the yeast survivability of the frozen or refrigerated dough containing the starch added yeast, the volume increase ratio of the product produced compared to wild-type yeast In addition, in the case of bread or Jeungpyun manufactured using recombinant yeast, cyclodextrin glucanotransferase is stably and continuously expressed on the surface of the recombinant yeast of the present invention, so processing starch material such as bread or Jeungpung containing starch By suppressing the aging of food to improve the quality of the food containing starch, and the shelf life of the product can be extended, its usefulness in the industrial, in particular with respect to the food industry.
<110> SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION <120> YEAST EXPRESSING CYCLODEXTRIN GLUCANOTRANSFERASE AND METHOD FOR USING THE SAME <130> dpp20064534kr <160> 7 <170> KopatentIn 1.71 <210> 1 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> KpnI-N for <400> 1 caccatcacc aggtacctat gaggaaagaa gcc 33 <210> 2 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> XhoI-C re <400> 2 gtaacaagcg gcctcgagcc tctacccgga gcc 33 <210> 3 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> Int-F <400> 3 accctcacta aagagctcaa aagctggcta g 31 <210> 4 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> Int-R <400> 4 gtgattaagc acacagagct cgcttggagt atg 33 <210> 5 <211> 2055 <212> DNA <213> Artificial Sequence <220> <223> CGT[3-18]-2 <220> <221> CDS <222> (1)..(2025) <400> 5 gcc ccg gat acc tcg gta tcc aac aag cag aat ttc agc acg gat gtc 48 Ala Pro Asp Thr Ser Val Ser Asn Lys Gln Asn Phe Ser Thr Asp Val 1 5 10 15 ata tat cag atc ttc acc gac cgg ttc tcg gac ggc aat ccg gcc aac 96 Ile Tyr Gln Ile Phe Thr Asp Arg Phe Ser Asp Gly Asn Pro Ala Asn 20 25 30 aat ccg acc ggc gcg gca ttt gac gga tca tgt acg aat ctt cgc tta 144 Asn Pro Thr Gly Ala Ala Phe Asp Gly Ser Cys Thr Asn Leu Arg Leu 35 40 45 tac tgc ggc ggc gac tgg caa ggc atc atc aac aaa atc aac gac ggt 192 Tyr Cys Gly Gly Asp Trp Gln Gly Ile Ile Asn Lys Ile Asn Asp Gly 50 55 60 tat ttg acc ggc atg ggc att acg gcc atc tgg att tca cag cct gtc 240 Tyr Leu Thr Gly Met Gly Ile Thr Ala Ile Trp Ile Ser Gln Pro Val 65 70 75 80 gag aat atc tac agc gtg atc aac tac tcc ggc gtc cat aat acg gct 288 Glu Asn Ile Tyr Ser Val Ile Asn Tyr Ser Gly Val His Asn Thr Ala 85 90 95 tat cac ggc tac tgg gcg cgg gac ttc aag aag acc aat ccg gcc tac 336 Tyr His Gly Tyr Trp Ala Arg Asp Phe Lys Lys Thr Asn Pro Ala Tyr 100 105 110 gga acg atg cag gac ttc aaa aac ctg atc gac acc gcg cat gcg cat 384 Gly Thr Met Gln Asp Phe Lys Asn Leu Ile Asp Thr Ala His Ala His 115 120 125 aac ata aaa gtc atc atc gac ttt gca ccg aac cat aca tct ccg gct 432 Asn Ile Lys Val Ile Ile Asp Phe Ala Pro Asn His Thr Ser Pro Ala 130 135 140 tct tcg gat gat cct tcc ttt gca gag aac ggc cgc ttg tac gat aac 480 Ser Ser Asp Asp Pro Ser Phe Ala Glu Asn Gly Arg Leu Tyr Asp Asn 145 150 155 160 ggc aac ctg ctc ggc gga tac acc aac gat acc caa aat ctg ttc cac 528 Gly Asn Leu Leu Gly Gly Tyr Thr Asn Asp Thr Gln Asn Leu Phe His 165 170 175 cat tat ggc ggc acg gat ttc tcc acc att gag aac ggc att tat aaa 576 His Tyr Gly Gly Thr Asp Phe Ser Thr Ile Glu Asn Gly Ile Tyr Lys 180 185 190 aac ctg tac gat ctg gct gac ctg aat cat aac aac agc agc gtc gat 624 Asn Leu Tyr Asp Leu Ala Asp Leu Asn His Asn Asn Ser Ser Val Asp 195 200 205 gtg tat ctg aag gat gcc atc aaa atg tgg ctc gac ctc ggg gtt gac 672 Val Tyr Leu Lys Asp Ala Ile Lys Met Trp Leu Asp Leu Gly Val Asp 210 215 220 ggc att cgc gtg gac gcg gtc aag cat acg cca ttc ggc tgg cag aag 720 Gly Ile Arg Val Asp Ala Val Lys His Thr Pro Phe Gly Trp Gln Lys 225 230 235 240 agc ttt atg tcc act att aac aac tac aag ccg gtc ttc acc att ggc 768 Ser Phe Met Ser Thr Ile Asn Asn Tyr Lys Pro Val Phe Thr Ile Gly 245 250 255 gaa tgg atc ctt ggc gtc aat gag att agt ccg gaa tac cat caa ttc 816 Glu Trp Ile Leu Gly Val Asn Glu Ile Ser Pro Glu Tyr His Gln Phe 260 265 270 gct aac gag tcc ggg atg agc ctg ctc gat ttc cgc ttt gcc cag aag 864 Ala Asn Glu Ser Gly Met Ser Leu Leu Asp Phe Arg Phe Ala Gln Lys 275 280 285 gcc cgg caa gtg ttc agg gac aac acc gac aat atg tac ggc ctg aaa 912 Ala Arg Gln Val Phe Arg Asp Asn Thr Asp Asn Met Tyr Gly Leu Lys 290 295 300 gcg atg ctg gag ggc tct gaa gta gac tat gcc cag gtg aat gac cag 960 Ala Met Leu Glu Gly Ser Glu Val Asp Tyr Ala Gln Val Asn Asp Gln 305 310 315 320 gtg acc ttc atc gac aat cat gac atg gag cgt ttc cac acc agc aat 1008 Val Thr Phe Ile Asp Asn His Asp Met Glu Arg Phe His Thr Ser Asn 325 330 335 ggc gac aga cgg aag ctg gag cag gcg ctg gcc ttt acc ctg act tca 1056 Gly Asp Arg Arg Lys Leu Glu Gln Ala Leu Ala Phe Thr Leu Thr Ser 340 345 350 cgc ggt gtg cct gcc atc tat tac ggc agc gag cag tat atg tct ggc 1104 Arg Gly Val Pro Ala Ile Tyr Tyr Gly Ser Glu Gln Tyr Met Ser Gly 355 360 365 ggg aat gat ccg gac aac cgt gct cgg att cct tcc ttc tcc acg acg 1152 Gly Asn Asp Pro Asp Asn Arg Ala Arg Ile Pro Ser Phe Ser Thr Thr 370 375 380 acg acc gca tat caa gtc atc caa aag ctc gct ccg ctc cgc aaa tcc 1200 Thr Thr Ala Tyr Gln Val Ile Gln Lys Leu Ala Pro Leu Arg Lys Ser 385 390 395 400 aac ccg gcc atc gct tac ggt tcc aca cag gag cgc tgg atc aac aac 1248 Asn Pro Ala Ile Ala Tyr Gly Ser Thr Gln Glu Arg Trp Ile Asn Asn 405 410 415 gat gtg atc atc tat gaa cgc aaa ttc ggc aat aac gtg gcc gtt gtt 1296 Asp Val Ile Ile Tyr Glu Arg Lys Phe Gly Asn Asn Val Ala Val Val 420 425 430 gcc att aac cgc aat atg aac aca ccg gct tcg att acc ggc ctt gtc 1344 Ala Ile Asn Arg Asn Met Asn Thr Pro Ala Ser Ile Thr Gly Leu Val 435 440 445 act tcc ctc ccg cag ggc agc tat aac gat gtg ctc ggc gga att ctg 1392 Thr Ser Leu Pro Gln Gly Ser Tyr Asn Asp Val Leu Gly Gly Ile Leu 450 455 460 aac ggc aat acg cta acc gtg ggt gct ggc ggt gca gct tcc aac ttt 1440 Asn Gly Asn Thr Leu Thr Val Gly Ala Gly Gly Ala Ala Ser Asn Phe 465 470 475 480 act ttg gct cct ggc ggc act gct gta tgg cag tac aca acc gat gcc 1488 Thr Leu Ala Pro Gly Gly Thr Ala Val Trp Gln Tyr Thr Thr Asp Ala 485 490 495 aca gct ccg atc atc ggc aat gtc ggc ccg atg atg gcc aag cca ggg 1536 Thr Ala Pro Ile Ile Gly Asn Val Gly Pro Met Met Ala Lys Pro Gly 500 505 510 gtc acg att acg att gac ggc cgc gct tcg gct cgg caa gga acg gtt 1584 Val Thr Ile Thr Ile Asp Gly Arg Ala Ser Ala Arg Gln Gly Thr Val 515 520 525 tac ttc ggt aca acg gca gtc act ggc gcg gac atc gta gct tgg gaa 1632 Tyr Phe Gly Thr Thr Ala Val Thr Gly Ala Asp Ile Val Ala Trp Glu 530 535 540 gat aca caa atc cag gtg aaa atc ctg cgg gtc cct ggc ggc atc tat 1680 Asp Thr Gln Ile Gln Val Lys Ile Leu Arg Val Pro Gly Gly Ile Tyr 545 550 555 560 gat atc aga gtt gcc aac gca gcc gga gca gcc agc aac atc tac gac 1728 Asp Ile Arg Val Ala Asn Ala Ala Gly Ala Ala Ser Asn Ile Tyr Asp 565 570 575 aat ttc gag gtg ctg acc gga gac cag gtc acc gtt cgg ttc gca atc 1776 Asn Phe Glu Val Leu Thr Gly Asp Gln Val Thr Val Arg Phe Ala Ile 580 585 590 aac aat gcc aca acg gcg ctg gga cag aat gtg ttc ctc acg ggc aat 1824 Asn Asn Ala Thr Thr Ala Leu Gly Gln Asn Val Phe Leu Thr Gly Asn 595 600 605 gtc agc gag ctg ggc aac tgg gat ccg aac aac gcg atc ggc ccg atg 1872 Val Ser Glu Leu Gly Asn Trp Asp Pro Asn Asn Ala Ile Gly Pro Met 610 615 620 tat aat cag gtc gtc tac caa tac ccg act tgg tat tat gat gtc agc 1920 Tyr Asn Gln Val Val Tyr Gln Tyr Pro Thr Trp Tyr Tyr Asp Val Ser 625 630 635 640 gtt ccg gca ggc caa acg att gaa ttt aaa ttc ctg aaa aag caa ggc 1968 Val Pro Ala Gly Gln Thr Ile Glu Phe Lys Phe Leu Lys Lys Gln Gly 645 650 655 tcc acc gtc aca tgg gaa ggc ggc gcg aat cgc acc ttc acc acc cca 2016 Ser Thr Val Thr Trp Glu Gly Gly Ala Asn Arg Thr Phe Thr Thr Pro 660 665 670 acc agc ggc acggc aacggtgaat gtgaactggc agcct 2055 Thr Ser Gly 675 <210> 6 <211> 675 <212> PRT <213> Artificial Sequence <400> 6 Ala Pro Asp Thr Ser Val Ser Asn Lys Gln Asn Phe Ser Thr Asp Val 1 5 10 15 Ile Tyr Gln Ile Phe Thr Asp Arg Phe Ser Asp Gly Asn Pro Ala Asn 20 25 30 Asn Pro Thr Gly Ala Ala Phe Asp Gly Ser Cys Thr Asn Leu Arg Leu 35 40 45 Tyr Cys Gly Gly Asp Trp Gln Gly Ile Ile Asn Lys Ile Asn Asp Gly 50 55 60 Tyr Leu Thr Gly Met Gly Ile Thr Ala Ile Trp Ile Ser Gln Pro Val 65 70 75 80 Glu Asn Ile Tyr Ser Val Ile Asn Tyr Ser Gly Val His Asn Thr Ala 85 90 95 Tyr His Gly Tyr Trp Ala Arg Asp Phe Lys Lys Thr Asn Pro Ala Tyr 100 105 110 Gly Thr Met Gln Asp Phe Lys Asn Leu Ile Asp Thr Ala His Ala His 115 120 125 Asn Ile Lys Val Ile Ile Asp Phe Ala Pro Asn His Thr Ser Pro Ala 130 135 140 Ser Ser Asp Asp Pro Ser Phe Ala Glu Asn Gly Arg Leu Tyr Asp Asn 145 150 155 160 Gly Asn Leu Leu Gly Gly Tyr Thr Asn Asp Thr Gln Asn Leu Phe His 165 170 175 His Tyr Gly Gly Thr Asp Phe Ser Thr Ile Glu Asn Gly Ile Tyr Lys 180 185 190 Asn Leu Tyr Asp Leu Ala Asp Leu Asn His Asn Asn Ser Ser Val Asp 195 200 205 Val Tyr Leu Lys Asp Ala Ile Lys Met Trp Leu Asp Leu Gly Val Asp 210 215 220 Gly Ile Arg Val Asp Ala Val Lys His Thr Pro Phe Gly Trp Gln Lys 225 230 235 240 Ser Phe Met Ser Thr Ile Asn Asn Tyr Lys Pro Val Phe Thr Ile Gly 245 250 255 Glu Trp Ile Leu Gly Val Asn Glu Ile Ser Pro Glu Tyr His Gln Phe 260 265 270 Ala Asn Glu Ser Gly Met Ser Leu Leu Asp Phe Arg Phe Ala Gln Lys 275 280 285 Ala Arg Gln Val Phe Arg Asp Asn Thr Asp Asn Met Tyr Gly Leu Lys 290 295 300 Ala Met Leu Glu Gly Ser Glu Val Asp Tyr Ala Gln Val Asn Asp Gln 305 310 315 320 Val Thr Phe Ile Asp Asn His Asp Met Glu Arg Phe His Thr Ser Asn 325 330 335 Gly Asp Arg Arg Lys Leu Glu Gln Ala Leu Ala Phe Thr Leu Thr Ser 340 345 350 Arg Gly Val Pro Ala Ile Tyr Tyr Gly Ser Glu Gln Tyr Met Ser Gly 355 360 365 Gly Asn Asp Pro Asp Asn Arg Ala Arg Ile Pro Ser Phe Ser Thr Thr 370 375 380 Thr Thr Ala Tyr Gln Val Ile Gln Lys Leu Ala Pro Leu Arg Lys Ser 385 390 395 400 Asn Pro Ala Ile Ala Tyr Gly Ser Thr Gln Glu Arg Trp Ile Asn Asn 405 410 415 Asp Val Ile Ile Tyr Glu Arg Lys Phe Gly Asn Asn Val Ala Val Val 420 425 430 Ala Ile Asn Arg Asn Met Asn Thr Pro Ala Ser Ile Thr Gly Leu Val 435 440 445 Thr Ser Leu Pro Gln Gly Ser Tyr Asn Asp Val Leu Gly Gly Ile Leu 450 455 460 Asn Gly Asn Thr Leu Thr Val Gly Ala Gly Gly Ala Ala Ser Asn Phe 465 470 475 480 Thr Leu Ala Pro Gly Gly Thr Ala Val Trp Gln Tyr Thr Thr Asp Ala 485 490 495 Thr Ala Pro Ile Ile Gly Asn Val Gly Pro Met Met Ala Lys Pro Gly 500 505 510 Val Thr Ile Thr Ile Asp Gly Arg Ala Ser Ala Arg Gln Gly Thr Val 515 520 525 Tyr Phe Gly Thr Thr Ala Val Thr Gly Ala Asp Ile Val Ala Trp Glu 530 535 540 Asp Thr Gln Ile Gln Val Lys Ile Leu Arg Val Pro Gly Gly Ile Tyr 545 550 555 560 Asp Ile Arg Val Ala Asn Ala Ala Gly Ala Ala Ser Asn Ile Tyr Asp 565 570 575 Asn Phe Glu Val Leu Thr Gly Asp Gln Val Thr Val Arg Phe Ala Ile 580 585 590 Asn Asn Ala Thr Thr Ala Leu Gly Gln Asn Val Phe Leu Thr Gly Asn 595 600 605 Val Ser Glu Leu Gly Asn Trp Asp Pro Asn Asn Ala Ile Gly Pro Met 610 615 620 Tyr Asn Gln Val Val Tyr Gln Tyr Pro Thr Trp Tyr Tyr Asp Val Ser 625 630 635 640 Val Pro Ala Gly Gln Thr Ile Glu Phe Lys Phe Leu Lys Lys Gln Gly 645 650 655 Ser Thr Val Thr Trp Glu Gly Gly Ala Asn Arg Thr Phe Thr Thr Pro 660 665 670 Thr Ser Gly 675 <210> 7 <211> 543 <212> DNA <213> Artificial Sequence <220> <223> delta sequence <400> 7 ggatccgcct acctttcacg agttgcgcag tttgtctgca agactctatg agaagcagat 60 aagcgataag tttgctcaac atcttctcgg gcataagtcg gacaccatgg catcacagta 120 tcgtgatgac agaggcaggg agtgggacaa aattgaaatc aaataatgat tttattttga 180 ctgatagtga cctgttcgtt gcaacaaatt gataagcaat gctttttttg agaaatgggt 240 gaatgttgag ataattgttg ggattccatt gttgataaag gctataatat taggtatcgg 300 tcgaccgata cagaatatac tagaagttct cctcaaggat ttaggaatcc ataaaaggga 360 atctgcaatt ctacacaatt ctataaatat tattatcatc attttatatg tttatattca 420 ttgatcctat tacattatca atccttgcgt ttcagcttcc actaatttag atgactattt 480 ctcatcattt gcgtcatctt ctaacaccgt atatgataat atactagtaa tgtaaatact 540 agt 543 <110> SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION <120> YEAST EXPRESSING CYCLODEXTRIN GLUCANOTRANSFERASE AND METHOD FOR USING THE SAME <130> dpp20064534kr <160> 7 <170> KopatentIn 1.71 <210> 1 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> KpnI-N for <400> 1 caccatcacc aggtacctat gaggaaagaa gcc 33 <210> 2 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> XhoI-C re <400> 2 gtaacaagcg gcctcgagcc tctacccgga gcc 33 <210> 3 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> Int-F <400> 3 accctcacta aagagctcaa aagctggcta g 31 <210> 4 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> Int-R <400> 4 gtgattaagc acacagagct cgcttggagt atg 33 <210> 5 <211> 2055 <212> DNA <213> Artificial Sequence <220> <223> CGT [3-18] -2 <220> <221> CDS (222) (1) .. (2025) <400> 5 gcc ccg gat acc tcg gta tcc aac aag cag aat ttc agc acg gat gtc 48 Ala Pro Asp Thr Ser Val Ser Asn Lys Gln Asn Phe Ser Thr Asp Val 1 5 10 15 ata tat cag atc ttc acc gac cgg ttc tcg gac ggc aat ccg gcc aac 96 Ile Tyr Gln Ile Phe Thr Asp Arg Phe Ser Asp Gly Asn Pro Ala Asn 20 25 30 aat ccg acc ggc gcg gca ttt gac gga tca tgt acg aat ctt cgc tta 144 Asn Pro Thr Gly Ala Ala Phe Asp Gly Ser Cys Thr Asn Leu Arg Leu 35 40 45 tac tgc ggc ggc gac tgg caa ggc atc atc aac aaa atc aac gac ggt 192 Tyr Cys Gly Gly Asp Trp Gln Gly Ile Ile Asn Lys Ile Asn Asp Gly 50 55 60 tat ttg acc ggc atg ggc att acg gcc atc tgg att tca cag cct gtc 240 Tyr Leu Thr Gly Met Gly Ile Thr Ala Ile Trp Ile Ser Gln Pro Val 65 70 75 80 gag aat atc tac agc gtg atc aac tac tcc ggc gtc cat aat acg gct 288 Glu Asn Ile Tyr Ser Val Ile Asn Tyr Ser Gly Val His Asn Thr Ala 85 90 95 tat cac ggc tac tgg gcg cgg gac ttc aag aag acc aat ccg gcc tac 336 Tyr His Gly Tyr Trp Ala Arg Asp Phe Lys Lys Thr Asn Pro Ala Tyr 100 105 110 gga acg atg cag gac ttc aaa aac ctg atc gac acc gcg cat gcg cat 384 Gly Thr Met Gln Asp Phe Lys Asn Leu Ile Asp Thr Ala His Ala His 115 120 125 aac ata aaa gtc atc atc gac ttt gca ccg aac cat aca tct ccg gct 432 Asn Ile Lys Val Ile Ile Asp Phe Ala Pro Asn His Thr Ser Pro Ala 130 135 140 tct tcg gat gat cct tcc ttt gca gag aac ggc cgc ttg tac gat aac 480 Ser Ser Asp Asp Pro Ser Phe Ala Glu Asn Gly Arg Leu Tyr Asp Asn 145 150 155 160 ggc aac ctg ctc ggc gga tac acc aac gat acc caa aat ctg ttc cac 528 Gly Asn Leu Leu Gly Gly Tyr Thr Asn Asp Thr Gln Asn Leu Phe His 165 170 175 cat tat ggc ggc acg gat ttc tcc acc att gag aac ggc att tat aaa 576 His Tyr Gly Gly Thr Asp Phe Ser Thr Ile Glu Asn Gly Ile Tyr Lys 180 185 190 aac ctg tac gat ctg gct gac ctg aat cat aac aac ag agc agc gtc gat 624 Asn Leu Tyr Asp Leu Ala Asp Leu Asn His Asn Asn Ser Ser Val Asp 195 200 205 gtg tat ctg aag gat gcc atc aaa atg tgg ctc gac ctc ggg gtt gac 672 Val Tyr Leu Lys Asp Ala Ile Lys Met Trp Leu Asp Leu Gly Val Asp 210 215 220 ggc att cgc gtg gac gcg gtc aag cat acg cca ttc ggc tgg cag aag 720 Gly Ile Arg Val Asp Ala Val Lys His Thr Pro Phe Gly Trp Gln Lys 225 230 235 240 agc ttt atg tcc act att aac aac tac aag ccg gtc ttc acc att ggc 768 Ser Phe Met Ser Thr Ile Asn Asn Tyr Lys Pro Val Phe Thr Ile Gly 245 250 255 gaa tgg atc ctt ggc gtc aat gag att agt ccg gaa tac cat caa ttc 816 Glu Trp Ile Leu Gly Val Asn Glu Ile Ser Pro Glu Tyr His Gln Phe 260 265 270 gct aac gag tcc ggg atg agc ctg ctc gat ttc cgc ttt gcc cag aag 864 Ala Asn Glu Ser Gly Met Ser Leu Leu Asp Phe Arg Phe Ala Gln Lys 275 280 285 gcc cgg caa gtg ttc agg gac aac acc gac aat atg tac ggc ctg aaa 912 Ala Arg Gln Val Phe Arg Asp Asn Thr Asp Asn Met Tyr Gly Leu Lys 290 295 300 gcg atg ctg gag ggc tct gaa gta gac tat gcc cag gtg aat gac cag 960 Ala Met Leu Glu Gly Ser Glu Val Asp Tyr Ala Gln Val Asn Asp Gln 305 310 315 320 gtg acc ttc atc gac aat cat gac atg gag cgt ttc cac acc agc aat 1008 Val Thr Phe Ile Asp Asn His Asp Met Glu Arg Phe His Thr Ser Asn 325 330 335 ggc gac aga cgg aag ctg gag cag gcg ctg gcc ttt acc ctg act tca 1056 Gly Asp Arg Arg Lys Leu Glu Gln Ala Leu Ala Phe Thr Leu Thr Ser 340 345 350 cgc ggt gtg cct gcc atc tat tac ggc agc gag cag tat atg tct ggc 1104 Arg Gly Val Pro Ala Ile Tyr Tyr Gly Ser Glu Gln Tyr Met Ser Gly 355 360 365 ggg aat gat ccg gac aac cgt gct cgg att cct tcc ttc tcc acg acg 1152 Gly Asn Asp Pro Asp Asn Arg Ala Arg Ile Pro Ser Phe Ser Thr Thr 370 375 380 acg acc gca tat caa gtc atc caa aag ctc gct ccg ctc cgc aaa tcc 1200 Thr Thr Ala Tyr Gln Val Ile Gln Lys Leu Ala Pro Leu Arg Lys Ser 385 390 395 400 aac ccg gcc atc gct tac ggt tcc aca cag gag cgc tgg atc aac aac 1248 Asn Pro Ala Ile Ala Tyr Gly Ser Thr Gln Glu Arg Trp Ile Asn Asn 405 410 415 gat gtg atc atc tat gaa cgc aaa ttc ggc aat aac gtg gcc gtt gtt 1296 Asp Val Ile Ile Tyr Glu Arg Lys Phe Gly Asn Asn Val Ala Val Val 420 425 430 gcc att aac cgc aat atg aac aca ccg gct tcg att acc ggc ctt gtc 1344 Ala Ile Asn Arg Asn Met Asn Thr Pro Ala Ser Ile Thr Gly Leu Val 435 440 445 act tcc ctc ccg cag ggc agc tat aac gat gtg ctc ggc gga att ctg 1392 Thr Ser Leu Pro Gln Gly Ser Tyr Asn Asp Val Leu Gly Gly Ile Leu 450 455 460 aac ggc aat acg cta acc gtg ggt gct ggc ggt gca gct tcc aac ttt 1440 Asn Gly Asn Thr Leu Thr Val Gly Ala Gly Gly Ala Ala Ser Asn Phe 465 470 475 480 act ttg gct cct ggc ggc act gct gta tgg cag tac aca acc gat gcc 1488 Thr Leu Ala Pro Gly Gly Thr Ala Val Trp Gln Tyr Thr Thr Asp Ala 485 490 495 aca gct ccg atc atc ggc aat gtc ggc ccg atg atg gcc aag cca ggg 1536 Thr Ala Pro Ile Ile Gly Asn Val Gly Pro Met Met Ala Lys Pro Gly 500 505 510 gtc acg att acg att gac ggc cgc gct tcg gct cgg caa gga acg gtt 1584 Val Thr Ile Thr Ile Asp Gly Arg Ala Ser Ala Arg Gln Gly Thr Val 515 520 525 tac ttc ggt aca acg gca gtc act ggc gcg gac atc gta gct tgg gaa 1632 Tyr Phe Gly Thr Thr Ala Val Thr Gly Ala Asp Ile Val Ala Trp Glu 530 535 540 gat aca caa atc cag gtg aaa atc ctg cgg gtc cct ggc ggc atc tat 1680 Asp Thr Gln Ile Gln Val Lys Ile Leu Arg Val Pro Gly Gly Ile Tyr 545 550 555 560 gat atc aga gtt gcc aac gca gcc gga gca gcc agc aac atc tac gac 1728 Asp Ile Arg Val Ala Asn Ala Ala Gly Ala Ala Ser Asn Ile Tyr Asp 565 570 575 aat ttc gag gtg ctg acc gga gac cag gtc acc gtt cgg ttc gca atc 1776 Asn Phe Glu Val Leu Thr Gly Asp Gln Val Thr Val Arg Phe Ala Ile 580 585 590 aac aat gcc aca acg gcg ctg gga cag aat gtg ttc ctc acg ggc aat 1824 Asn Asn Ala Thr Thr Ala Leu Gly Gln Asn Val Phe Leu Thr Gly Asn 595 600 605 gtc agc gag ctg ggc aac tgg gat ccg aac aac gcg atc ggc ccg atg 1872 Val Ser Glu Leu Gly Asn Trp Asp Pro Asn Asn Ala Ile Gly Pro Met 610 615 620 tat aat cag gtc gtc tac caa tac ccg act tgg tat tat gat gtc agc 1920 Tyr Asn Gln Val Val Tyr Gln Tyr Pro Thr Trp Tyr Tyr Asp Val Ser 625 630 635 640 gtt ccg gca ggc caa acg att gaa ttt aaa ttc ctg aaa aag caa ggc 1968 Val Pro Ala Gly Gln Thr Ile Glu Phe Lys Phe Leu Lys Lys Gln Gly 645 650 655 tcc acc gtc aca tgg gaa ggc ggc gcg aat cgc acc ttc acc acc cca 2016 Ser Thr Val Thr Trp Glu Gly Gly Ala Asn Arg Thr Phe Thr Thr Pro 660 665 670 acc agc ggc acggc aacggtgaat gtgaactggc agcct 2055 Thr Ser Gly 675 <210> 6 <211> 675 <212> PRT <213> Artificial Sequence <400> 6 Ala Pro Asp Thr Ser Val Ser Asn Lys Gln Asn Phe Ser Thr Asp Val 1 5 10 15 Ile Tyr Gln Ile Phe Thr Asp Arg Phe Ser Asp Gly Asn Pro Ala Asn 20 25 30 Asn Pro Thr Gly Ala Ala Phe Asp Gly Ser Cys Thr Asn Leu Arg Leu 35 40 45 Tyr Cys Gly Gly Asp Trp Gln Gly Ile Ile Asn Lys Ile Asn Asp Gly 50 55 60 Tyr Leu Thr Gly Met Gly Ile Thr Ala Ile Trp Ile Ser Gln Pro Val 65 70 75 80 Glu Asn Ile Tyr Ser Val Ile Asn Tyr Ser Gly Val His Asn Thr Ala 85 90 95 Tyr His Gly Tyr Trp Ala Arg Asp Phe Lys Lys Thr Asn Pro Ala Tyr 100 105 110 Gly Thr Met Gln Asp Phe Lys Asn Leu Ile Asp Thr Ala His Ala His 115 120 125 Asn Ile Lys Val Ile Ile Asp Phe Ala Pro Asn His Thr Ser Pro Ala 130 135 140 Ser Ser Asp Asp Pro Ser Phe Ala Glu Asn Gly Arg Leu Tyr Asp Asn 145 150 155 160 Gly Asn Leu Leu Gly Gly Tyr Thr Asn Asp Thr Gln Asn Leu Phe His 165 170 175 His Tyr Gly Gly Thr Asp Phe Ser Thr Ile Glu Asn Gly Ile Tyr Lys 180 185 190 Asn Leu Tyr Asp Leu Ala Asp Leu Asn His Asn Asn Ser Ser Val Asp 195 200 205 Val Tyr Leu Lys Asp Ala Ile Lys Met Trp Leu Asp Leu Gly Val Asp 210 215 220 Gly Ile Arg Val Asp Ala Val Lys His Thr Pro Phe Gly Trp Gln Lys 225 230 235 240 Ser Phe Met Ser Thr Ile Asn Asn Tyr Lys Pro Val Phe Thr Ile Gly 245 250 255 Glu Trp Ile Leu Gly Val Asn Glu Ile Ser Pro Glu Tyr His Gln Phe 260 265 270 Ala Asn Glu Ser Gly Met Ser Leu Leu Asp Phe Arg Phe Ala Gln Lys 275 280 285 Ala Arg Gln Val Phe Arg Asp Asn Thr Asp Asn Met Tyr Gly Leu Lys 290 295 300 Ala Met Leu Glu Gly Ser Glu Val Asp Tyr Ala Gln Val Asn Asp Gln 305 310 315 320 Val Thr Phe Ile Asp Asn His Asp Met Glu Arg Phe His Thr Ser Asn 325 330 335 Gly Asp Arg Arg Lys Leu Glu Gln Ala Leu Ala Phe Thr Leu Thr Ser 340 345 350 Arg Gly Val Pro Ala Ile Tyr Tyr Gly Ser Glu Gln Tyr Met Ser Gly 355 360 365 Gly Asn Asp Pro Asp Asn Arg Ala Arg Ile Pro Ser Phe Ser Thr Thr 370 375 380 Thr Thr Ala Tyr Gln Val Ile Gln Lys Leu Ala Pro Leu Arg Lys Ser 385 390 395 400 Asn Pro Ala Ile Ala Tyr Gly Ser Thr Gln Glu Arg Trp Ile Asn Asn 405 410 415 Asp Val Ile Ile Tyr Glu Arg Lys Phe Gly Asn Asn Val Ala Val Val 420 425 430 Ala Ile Asn Arg Asn Met Asn Thr Pro Ala Ser Ile Thr Gly Leu Val 435 440 445 Thr Ser Leu Pro Gln Gly Ser Tyr Asn Asp Val Leu Gly Gly Ile Leu 450 455 460 Asn Gly Asn Thr Leu Thr Val Gly Ala Gly Gly Ala Ala Ser Asn Phe 465 470 475 480 Thr Leu Ala Pro Gly Gly Thr Ala Val Trp Gln Tyr Thr Thr Asp Ala 485 490 495 Thr Ala Pro Ile Ile Gly Asn Val Gly Pro Met Met Ala Lys Pro Gly 500 505 510 Val Thr Ile Thr Ile Asp Gly Arg Ala Ser Ala Arg Gln Gly Thr Val 515 520 525 Tyr Phe Gly Thr Thr Ala Val Thr Gly Ala Asp Ile Val Ala Trp Glu 530 535 540 Asp Thr Gln Ile Gln Val Lys Ile Leu Arg Val Pro Gly Gly Ile Tyr 545 550 555 560 Asp Ile Arg Val Ala Asn Ala Ala Gly Ala Ala Ser Asn Ile Tyr Asp 565 570 575 Asn Phe Glu Val Leu Thr Gly Asp Gln Val Thr Val Arg Phe Ala Ile 580 585 590 Asn Asn Ala Thr Thr Ala Leu Gly Gln Asn Val Phe Leu Thr Gly Asn 595 600 605 Val Ser Glu Leu Gly Asn Trp Asp Pro Asn Asn Ala Ile Gly Pro Met 610 615 620 Tyr Asn Gln Val Val Tyr Gln Tyr Pro Thr Trp Tyr Tyr Asp Val Ser 625 630 635 640 Val Pro Ala Gly Gln Thr Ile Glu Phe Lys Phe Leu Lys Lys Gln Gly 645 650 655 Ser Thr Val Thr Trp Glu Gly Gly Ala Asn Arg Thr Phe Thr Thr Pro 660 665 670 Thr Ser Gly 675 <210> 7 <211> 543 <212> DNA <213> Artificial Sequence <220> <223> delta sequence <400> 7 ggatccgcct acctttcacg agttgcgcag tttgtctgca agactctatg agaagcagat 60 aagcgataag tttgctcaac atcttctcgg gcataagtcg gacaccatgg catcacagta 120 tcgtgatgac agaggcaggg agtgggacaa aattgaaatc aaataatgat tttattttga 180 ctgatagtga cctgttcgtt gcaacaaatt gataagcaat gctttttttg agaaatgggt 240 gaatgttgag ataattgttg ggattccatt gttgataaag gctataatat taggtatcgg 300 tcgaccgata cagaatatac tagaagttct cctcaaggat ttaggaatcc ataaaaggga 360 atctgcaatt ctacacaatt ctataaatat tattatcatc attttatatg tttatattca 420 ttgatcctat tacattatca atccttgcgt ttcagcttcc actaatttag atgactattt 480 ctcatcattt gcgtcatctt ctaacaccgt atatgataat atactagtaa tgtaaatact 540 agt 543
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070062353A KR100921979B1 (en) | 2007-06-25 | 2007-06-25 | Yeast expressing cyclodextrin glucanotransferase and method for using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070062353A KR100921979B1 (en) | 2007-06-25 | 2007-06-25 | Yeast expressing cyclodextrin glucanotransferase and method for using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080113624A true KR20080113624A (en) | 2008-12-31 |
KR100921979B1 KR100921979B1 (en) | 2009-10-14 |
Family
ID=40370852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070062353A KR100921979B1 (en) | 2007-06-25 | 2007-06-25 | Yeast expressing cyclodextrin glucanotransferase and method for using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100921979B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009023083A1 (en) | 2008-11-14 | 2010-05-20 | Samsung Electro - Mechanics Co., Ltd., Suwon | Complementary metal oxide semiconductor amplifier circuit, has lower amplifier unit comprising transistor controlled based on error voltage for amplifying signal and for compensating variation of transconductance of main amplifier unit |
-
2007
- 2007-06-25 KR KR1020070062353A patent/KR100921979B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009023083A1 (en) | 2008-11-14 | 2010-05-20 | Samsung Electro - Mechanics Co., Ltd., Suwon | Complementary metal oxide semiconductor amplifier circuit, has lower amplifier unit comprising transistor controlled based on error voltage for amplifying signal and for compensating variation of transconductance of main amplifier unit |
Also Published As
Publication number | Publication date |
---|---|
KR100921979B1 (en) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5715346B2 (en) | Food modification method using β-amylase | |
JP6115921B2 (en) | Maltotriosyltransferase, production method thereof and use | |
US11142748B2 (en) | Saccharide oxidase, and production method for same and use of same | |
JP6280962B2 (en) | New uses of maltotriosyltransferase | |
JPH11509082A (en) | Enzymes having aminopeptidase activity | |
WO1998044804A1 (en) | Improved method for preparing flour doughs and products made from such doughs using glycerol oxidase | |
AU2010285965A1 (en) | Food product containing starch gel | |
JPWO2019189065A1 (en) | Manufacturing method of starch-containing foods | |
CN1326990C (en) | Gamma-glutamylcysteine-producing yeast | |
KR101647477B1 (en) | Cookie with an improved quality and method of preparing the same | |
KR100921979B1 (en) | Yeast expressing cyclodextrin glucanotransferase and method for using the same | |
JP6595270B2 (en) | Food improver | |
JP6434983B2 (en) | Uses of new α-glucosidase | |
WO2020145371A1 (en) | Method for manufacturing starch-containing food | |
KR101929346B1 (en) | Manufaturing method of a rice nuruk using aspergillus oryzae 83-10 and rice nuruk manufactured by same method | |
KR101259622B1 (en) | Method for preparing par-baked frozen dough using wheat | |
JP7278094B2 (en) | Novel use of branching enzymes in dough or cooked dough foods | |
EP3896157A1 (en) | Polypeptide with xylanase activity, nucleotide sequence encoding it, ingredient and process comprising said ingredient for preparing a food product | |
JP2020058318A (en) | Novel uses of branching enzymes in dough or dough heated foods | |
JP2021159014A (en) | Method for producing enzyme-containing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121005 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20130930 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140929 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20151001 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170928 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20191002 Year of fee payment: 11 |